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“Until treatment is totally effective and side effects non-existent it is important that the quality 
of life of patients undergoing cancer treatment is properly evaluated” Peter Selby, 1985.1
Background
Quality of life (QoL) is considered to be as an important outcome for evaluating the 
impact of disease, and for assessing the effectiveness of treatment. QoL is particularly 
relevant for cancer patients who are willing to undergo risky and toxic treatment.2-5
Indeed, when treatment has no apparent beneﬁts with regard to survival, possible 
effects on QoL can become the deciding factor. However, even if there are no survival 
beneﬁts, chemotherapy can provide important palliative beneﬁts.This is especially 
so in patients with small-cell lung cancer (SCLC), for whom therapy is unlikely to 
be curative. Therefore, understanding the relative effects of chemotherapy on QoL 
is important for decision-making, and even more vital in daily clinical practice for 
optimizing the QoL of these patients throughout the course of their illness.6
However, QoL research often yields counter-intuitive and paradoxical ﬁndings which 
raise questions about what QOL measurement instruments actually assess, and how the 
scores should be interpreted. For example, Groen et al. studied patients with inoperable 
non-SCLC treated by radiation with and without chemotherapy.7 QoL was measured 
with the European Organization for Research and Treatment of Cancer Core Quality 
of Life Questionnaire ( EORTC QLQ-C30) 8, which has been designed speciﬁcally for 
use in clinical trials focusing on cancer patients. However, contrary to expectations, 
they found no signiﬁcant deterioration in the scores over the 6-week treatment period. 
Furthermore, patients with a life-threatening disease reported a stable QoL, and the 
level of QoL of patients with a severe chronic illness was found to be no worse no 
better than that of less severely ill patients or healthy people.9-13 Such counter-intuitive 
ﬁndings, labelled by Breetvelt and Van Dam as ‘under-reporting of problems’, suggest 
that patients report less distress and dissatisfaction than they actually experience.12
Several studies show that patients’ own evaluations may differ considerably from 
those made by clinicians and signiﬁcant others.14;15 In short, QoL measures do not 
consistently distinguish known groups, they are often only weakly related to objective 
criteria, and they show little convergence across measurement perspectives.16
It is suggested that patients make the best of their condition by coping, rethinking 
and reframing their experiences, and that this adaptive self-regulation may explain 
these discrepancies.17-19 In recent years, the response shift theory has gained increasing 
acceptance in explaining paradoxical and counter-intuitive ﬁndings. Response shift 
refers to a change in internal standards, values and conceptualization of QoL, and 
it is recognized as an important mediator in adaptation to changing health status.17
However, despite the explanatory power of the response shift theory, our current 
understanding of phenomena that can complicate the interpretation of QoL scores is 
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still limited.20 Although the occurrence of response shift might complicate ‘objective’ 
evaluation of QoL and treatment 17-22 , it could also be seen as a desirable outcome of 
adaptation. From both perspectives it is therefore necessary to explore response shift 
and other phenomena that can complicate the interpretation of QoL scores.
Response shift
If a test or measurement is reliable, one usually assumes that the construct that is 
being assessed is stable, for example the assessment of temperature or blood pressure. 
If one interprets a change in QoL over time (or a difference between groups) as an 
actual change (or difference), one assumes that the concept of QoL itself remains the 
same over time (or between groups), in the same way as the concepts of temperature 
and blood pressure remain the same over time. Response shift complicates such 
interpretations, due to recalibration, change in values or reconceptualization.
The concept of response shift originated in the 1970’s during research on educational 
training interventions (Howard et al. 23) and organizational change (Golembiewski 
et al.24). Howard deﬁned response shift in terms of changes in internal standards 
of measurement, whereas Golembiewski also introduced the component of 
reconceptualization in addition to this scale racalibration; changes in values are 
inherent in Golembiewski reconceptualization. Sprangers & Schwartz introduced 
reconceptualization as a separate component in their theoretical model of response 
shift (see Figure 1).17 Response shift is deﬁned as “a change in the meaning of one’s 
self-evaluation of a target construct as a result of: a) a change in the respondent’s 
internal standards of measurement (scale recalibration, in psychometric terms); b) 
a change in the respondent’s values (i.e. the importance of component domains 
constituting the target construct); or c) a redeﬁnition of the target construct (i.e. 
reconceptualization)”. Sprangers & Schwartz emphasize that the extent to which the 
three components are distinct or interconnected is unknown.
The theoretical model has ﬁve major components: 1) Catalysts refer to a change 
in the respondent’s health status that may or may not result from treatment; 2) 
Antecedents include personal characteristics, such as gender, education, personality, 
expectations; 3) Mechanisms encompass behavioural, cognitive, or affective processes 
to accommodate changes in catalysts (initiating social comparisons, reordering 
goals); 4) Response shift includes changes in the meaning of one’s self-evaluation of 
QoL, resulting from changes in internal standards, values, or conceptualization; and 
5) Perceived QoL can be deﬁned as a multidimensional construct incorporating at least 
the three domains of physical, psychological and social functioning. The model uses 
a dynamic feedback loop to explain how QoL scores can be stabilized, despite changes 
in health status.
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Measurement of response shift in QoL
Schwartz & Sprangers 22 describe and evaluate a number of different approaches to 
the measurement of response shift and the identiﬁcation of recalibration, change in 
values and reconceptualization. Two categories of approaches appear to be immediately 
applicable in QoL research, because already existing QoL instruments can be used. One 
category consists of ‘design approaches’, of which the ‘then-test’ is an example. The 
then-test consists of an additional measurement with the same QoL instrument that has 
been used for QoL measurement (though with different instructions for the patient). 
The other category consists of ‘individualized methods’ which are characterized by 
the fact that from the outset they are not intended to measure a stable concept, but 
require that respondents deﬁne the concept for the moment of measurement only. The 
Schedule for the Evaluation of Individual Quality of Life – Direct Weighting (SEIQoL-
DW)25 is such an individualized approach which measures QoL from the unique 
individual perspective. Patients can choose, rate and weight ﬁve domains (cues) that 
they consider important. At different points in time, patients might nominate different 
cues, and they might give the same cues a different weight. As Schwartz & Sprangers 
have indicated, both changes are indicative of a change in values. 
Figure 1. A theoretical model of response shift and quality of life (QOL).17 “Integrating response 
shift into health-related quality of life research: a theoretical model” by M.A.Sprangers and C.E. 
Schwartz, 1999, Social Science and Medicine, 48(11), pp.1507-1515.
Why small-cell lung cancer patients?
Worldwide, lung cancer is one of the most frequently occurring forms of cancer, with 
a high mortality rate in both men and women.26-28 Lung cancer is usually sub-divided 
in non-SCLC and SCLC. The ﬁrst category accounts for about three-quarters of all 
lung cancers, and has a slower progression rate than the second category. Apart from 
being a relatively fast-growing form of lung cancer, SCLC is also early spreading, and 
metastases are almost always present at the time of the initial diagnosis. Standard 
therapy for SCLC is systematic treatment with chemotherapy (4-6 cycles). If the SCLC 
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is limited, the patients will receive chemotherapy with concurrent radiotherapy. But 
even after a successful initial course of chemotherapy there is a very high rate of early 
recurrence, resulting in limited survival. For more than 90% of the patients, extensive 
SCLC is fatal within 2 years of diagnosis. Nevertheless, compared with supportive 
care, chemotherapy offers substantial beneﬁts by improving both the quality and the 
quantity of life within this limited period. Patients with limited disease have a median 
survival period of 12-16 months, and those with extensive have 7-12 months.28 The 
treatment of SCLC patients is not aimed at recovery, but at prolonging and enhancing 
the quality of the patient’s life, and therefore the correct interpretation of QoL scores 
is of major importance. An important reason for selecting SCLC patients for our study 
was that the general illness trajectory was already known and described by The 29, and 
this provided us with essential background knowledge for the design of the study. The 
average illness trajectory of SCLC patients is relatively short, so complete trajectories 
could be covered in a four-year study.
Research questions
In this thesis we explore response shift in QoL in the palliative treatment of SCLC 
patients.
Listen to the patient
This ﬁrst part of the thesis focuses on response shift and other explanations to 
account for counter-intuitive ﬁndings in the measurement of QoL by means of 
EORTC questionnaires. 
1.  Is the then-test a useful approach to determine whether a recalibration response 
shift has occurred?
2.  Can response shift explain counter-intuitive ﬁndings sufﬁciently in the 
measurement of QoL?
Focus on what really matters
The second part of the thesis addresses the elicitation of QoL domains (cues), change 
in what really matters to patients, and the measurement of response shift (i.e. 
reconceptualization and change in values) in individual QoL. 
3.  Is SEIQoL-DW a reliable instrument in providing all the relevant information that 
is needed to determine wether a response shift (i.e. reconceptualization and change 
in values) has occurred?
Understand the struggle behind “I’m all right”
The third part of the thesis describes how patients manage to cope with their incurable 
disease.
4. What are the factors that result in positive self-reports, despite deteriorating health?
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Methods
To answer the research questions a qualitative exploratory longitudinal study was 
designed, and various methods of data-collection were used. These methods were a 
mix of techniques and procedures which are derived from different research traditions. 
The way in which these various methods are integrated, and the way in which the 
resulting data were analysed, is based on the (longitudinal, multiple) qualitative case-
study.30 To fully understand changes in standards, values and concepts and, moreover 
in QoL, it was necessary to probe beyond quantitative responses to discover what 
mattered to the patient. In a qualitative, semi-structured interview we encouraged 
patients to tell us in their own words what they valued (most) in their life (at that 
speciﬁc point in time, in their current circumstances). We were not only interested 
in collecting qualitative data from the patients about (changes in) standards, values 
and concepts, but we also wanted to relate such data to actual measurements of QoL 
obtained with established measurement instruments. We used the EORTC QLQ-C30 
and the QLQ-CL13 for this purpose because they are the current European standard 
for trials involving (lung) cancer patients. A ‘think aloud’ procedure was used (see 
Method sections of Chapter 2 and 3 for further details). Response shift (i.e. change 
in internal standards) in EORTC QLQ measurements was assessed by means of the 
‘then-test’. We used the SEIQoL to measure individual QoL, because it not only gives 
patients the opportunity to describe their own perspective, but also because it is one 
of the few QoL measures that explicitly take reconceptualization and change in values 
into account. The main reason for using both the EORTC and the SEIQoL (instead of 
only one measure) was that we wanted to explore actual change in QoL and response 
shift in QoL from as broad a perspective as possible. By presenting a large variety of 
QoL stimuli to patients in different contexts (i.e. different QoL measures), we provided 
them with the opportunity to reﬂect on a broad range of aspects of QoL.
Outline of this thesis 
In this thesis, we investigated adaptation in the illness trajectory of SCLC patients 
by means of observations made by the QoL researcher and also from the patient’s 
perspective. Chapters 2 to 6 of this thesis are based on articles which have already 
been published, accepted or submitted for publication. This implies that various 
chapters overlap, especially with regard to the Methods sections. Chapters 2 and 3 
describe the measurement of QoL with the EORTC questionnaires, the use of the 
then-test in exploring changes in internal standards, and the investigation of other 
phenomena complicating the interpretations of QoL scores. Chapters 4 and 5 describe 
the measurement of individual QoL, and the usefulness of SEIQoL-DW in assessing 
adaptation to changing health, reconceptualization and change in values. Chapter 6 
describes how patients manage to cope with their incurable disease. Finally, Chapter 
7 presents an overview of what we have accomplished, implications of the ﬁndings 
are discussed, and we conclude with recommendations for further research.
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Small-cell lung cancer patients are just ‘a little bit’ tired: 
response shift and self-presentation in
the measurement of fatigue 2
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Abstract
Background
Response shift has gained increasing attention in the measurement of health-
related quality of life (QoL) as it may explain counter-intuitive ﬁndings as a result of 
adaptation to deteriorating health. 
Objective
To search for response shift type explanations to account for counter-intuitive ﬁndings 
in QoL measurement. 
Methods
Qualitative investigation of the response behaviour of small-cell lung cancer patients 
(n=23) in the measurement of fatigue with the EORTC QLQ-C30 question ‘were you 
tired’. Interviews were conducted at four points during 1st line chemotherapy: at the 
start of chemotherapy, four weeks later, at the end of chemotherapy, and six weeks 
later. Patients were asked to ‘think aloud’ when ﬁlling in the questionnaire.
Results
Fifteen patients showed discrepancies between their answer to the EORTC question 
‘were you tired’ and their level of fatigue spontaneously reported during the interview. 
These patients chose the response options ‘not at all’ or ‘a little’ and explained their 
answers in various ways. In patients with and without discrepancies, we found 
indications of recalibration response shift (e.g. using a different comparison standard 
over time) and of change in perspective (e.g. change towards a more optimistic 
perspective). Patients in the discrepancy group reported spontaneously how they dealt 
with diagnosis and treatment, i.e. by adopting protective and assertive behaviour and 
by ﬁghting the stigma. They distanced themselves from the image of the stereotypical 
cancer patient and presented themselves as not suffering and accepting fatigue as 
consequence of treatment.
Conclusion
In addition to response shift, this study suggests that ‘self-presentation’ might be 
an important mechanism affecting quality of life measurement, particularly during 
phases when a new equilibrium needs to be found.
Westerman_v3.indd   22 18-07-2007   13:00:30
C
h
ap
te
r 
2
23
Introduction
Quality of life (QoL) is considered an important treatment outcome when the 
treatment intent is not curative but palliative. However, the expected deterioration 
in QoL often does not occur, even in cases of serious illness. For example, Groen et al.
studied patients with inoperable non-small cell lung cancer treated by radiation with 
and without chemotherapy.1 QoL was measured with The European Organization 
for Research and Treatment of Cancer Core Quality of Life Questionnaire( EORTC
QLQ-C30) 2, which has been designed speciﬁcally for use in clinical trials focusing 
on cancer patients. However, contrary to expectation, they did not ﬁnd signiﬁcant 
deterioration in the scale scores over the treatment period of 6 weeks. Although cancer 
patients are willing to undergo risky and toxic treatments3, it seemed implausible that 
the side-effects of treatment had not affected their QoL. Other studies also reported 
counter-intuitive results. For example, patients with a life-threatening disease or 
disability were found to report stable QoL, and patients with a severe chronic illness 
reported QoL levels that were not inferior to that of patients with a less severe illness 
or to healthy patients.4-6 Such counter-intuitive ﬁndings, labelled by Breetvelt and 
Van Dam as ‘underreporting of problems’ suggest that patients report less distress and 
dissatisfaction than they actually feel.6
In recent years, response shift theory has gained increasing attention in explaining 
paradoxical and counter-intuitive ﬁndings. Response shift refers to a change in internal 
standards, values and conceptualization of QoL and is recognized as an important 
mediator in adaptation to changing health.7 However, despite the explanatory power 
of response shift theory, our current understanding of phenomena that can complicate 
the interpretation of QoL scores is still limited. Therefore, we investigated QoL 
measurement in small-cell lung cancer (SCLC) patients during 1st line chemotherapy. 
We were quite surprised when we noticed discrepancies between levels of fatigue 
measured with the questionnaire and answers spontaneously reported during the 
interview. We therefore investigated these ‘conﬂicting’ ﬁndings in the measurement 
of QoL in more depth.
This paper reports the results of an exploratory longitudinal multiple-case study, in 
which we focused on how patients responded to the EORTC QLQ-C30 question ‘were 
you tired’ at different points in their treatment trajectory. We aimed to describe the 
patients’ explanations when answering the question, and to search for explanations 
of counter-intuitive ﬁndings. 
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Figure 1 Analysis by means of a mind map. Branch EORTC: scores of GH/QOL and the fatigue 
scale are organized per interview and complemented by the think aloud data. Branch Comments: 
core texts of relevant parts of transcripts are organized per code and per interview.
Note: (+) not all branches of the different interview moments are shown.
Methods
Procedures and study sample
Between March 2001 and September 2003, we recruited newly-diagnosed patients 
with SCLC who were evaluated for 1st line chemotherapy. The patients were attending 
one of ﬁve outpatient clinics for chest diseases in the Netherlands. To maximize the 
likelihood that we would interview patients from the beginning of their treatment, 
we were informed about new patients immediately after diagnosis. No restrictions 
were made with regard to age or treatment (chemotherapy or a combination of 
chemotherapy and radiotherapy). Participating patients gave written consent and 
were interviewed at equivalent points in the treatment trajectory. The ﬁrst interview 
(T1) was carried out at the start of chemotherapy. In the original plan the second 
interview was planned after completion of the course of chemotherapy. However, 
after inclusion and ﬁrst interviews of 3 patients we made a decision to interview 
the patients during treatment as well. Therefore the second interview (T2) was 
conducted four weeks after T1 and the third (T3) 7-10 days after completion of the 
treatment with chemotherapy and the fourth (T4) six weeks later. Approval for this 
study was obtained from the Medical Ethics Committees of the research site and the 
participating hospitals. 
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During the course of the study, 41 eligible patients were invited to the study. 
Four patients were unwilling to participate, 3 died before informed consent could 
be obtained, and 3 were not interviewed because of imminent death. Of the 31 
respondents who were interviewed, 8 were excluded from further analysis because 
their data were incomplete, i.e. they were only interviewed once (six died within a 
month after T1 and two were too sick at T2 and died before the end of the planned 
chemotherapy). Consequently, the ﬁnal study sample consisted of 23 SCLC patients, 
of whom12 had limited (3 male and 9 female, mean age 55, range 42-69) and 11 
had extensive disease (8 male and 3 female, mean age 64, range 39-72). All patients 
received standard chemotherapy, except for 7 patients whose chemotherapy was 
combined with local radiation of the tumour. The majority of the patients were 
married (19, 83%), and had children (17, 74%). 
Of the 23 patients in our study sample, 15 were interviewed four times, 7 were 
interviewed three times, and one patient was only interviewed twice resulting in a 
total of 83 interviews. The interviews were conducted by MW in the homes of the 
patients. In three cases the 1st interview was held in the hospital. Interviews averaged 
80-110 min. 
Materials and qualitative method
In this exploratory, longitudinal multiple-case study, QoL was assessed with EORTC 
QLQ-C30 (version 3.0)2 and the lung cancer module QLQ-CL13.8 The EORTC QLQ-
C30 is the most widely used cancer-speciﬁc QoL instrument in European clinical 
trials. The questionnaire is composed of several scales, which measure among others 
physical function, mental health, general health and global QoL. Furthermore, it 
measures different symptoms such as pain, dyspnoea, nausea and fatigue. The Fatigue 
Scale consists of 3 items: ‘did you need to rest’, ‘have you felt weak’ and ‘were you 
tired’ (respectively questions 10, 12 and 18), for which there are 4 response categories: 
‘not at all’, ‘a little’, ‘quite a bit’ and ‘very much’ (respectively scores 1, 2, 3 and 4).
The EORTC QLQ-C30 and CL13 were completed in combination with the Three-Step 
Test-Interview (TSTI) to investigate how respondents interpreted the items and how 
they responded to them. The TSTI consists of the following steps9 : 1) concurrent think 
aloud, aimed at collecting observational data on how a respondent completes the 
questionnaire, expressing his thoughts aloud; 2) focused interview, aimed at clarifying 
respondents’ previous expressions while completing the questionnaire; 3) semi-
structured interview, aimed at eliciting respondents’ experiences and opinions with 
regard to the questionnaire. 
Interview protocol
Each interview was conducted in an identical format. At T1, QoL was measured with the 
EORTC QLQ-C30, followed by the lung cancer module QLQ-CL13. The questionnaire 
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was conducted in a concurrent think aloud manner and after completion, respondents 
were asked to clarify previous hesitations, expressions when rating certain items 
and experiences (i.e. second and third step of the TSTI). Individual QoL was then 
measured with the Schedule for the Evaluation of Individual Quality of Life – Direct 
Weighting (SEIQoL-DW).10-11 Finally, we encouraged patients to talk freely about the 
impact of diagnosis and treatment. At follow-up (i.e. T2, T3 and T4), after the SEIQoL-
DW assessment, the EORTC questionnaires were administered a second time as a 
so-called ‘then-test’ 12-14 (i.e. the patients ﬁlled out the questionnaire in reference to 
how they perceived themselves as they were in the previous interview). In these 2nd
and following interviews, EORTC assessments were conducted in a concurrent think 
aloud manner and with the second step of TSTI integrated in the assessment. In fact, 
we encouraged patients to think aloud and we probed for clariﬁcation after each item 
in the case of extra information was considered useful to understand patients’ answer. 
We used a ﬂexible approach in order not to interrupt the natural ﬂow of both the 
assessment as well as the patient-interviewer communication.
The interviews were audio-taped and transcribed verbatim. In this article we focus on 
the EORTC QLQ-C30 question ‘were you tired’.
Analysis
Three types of data were collected and used for analysis 15:1) completed EORTC 
questionnaires (T1-T4), 2) observed respondent behaviour recorded in ﬁeld notes, and 
3) transcriptions of the interviews, including ’think aloud’. The analysis was aimed at 
identifying discrepancies, response strategies and explanations of response behaviour. 
We used the qualitative computer package Kwalitan 5.0 (http://www.kwalitan.net) to 
extract relevant parts of the transcriptions: 1) ‘think aloud’ of the question ‘were you 
tired’ and of other items that were useful in understanding the response behaviour to 
the question on fatigue (i.e. two other items of the fatigue scale, the general health 
and the global QoL question of the QLQ-C30), and 2) ‘comments’ related to fatigue 
symptoms, impact of treatment on perceived QoL, and attitudes towards life. In order 
to deal with the still remaining large amount of extracted data, two of the authors 
(MW, AT) condensed extracted transcripts of the ‘comments’ into core texts. For each 
patient, the data (i.e. think aloud combined with scores and core texts of comments) 
were organized per interview in one mind map (see example in Figure 1) by means 
of the computer package Mindjet Mindmanager Pro 6 (http://www.mindjet.com).
Furthermore, a different mind map was made to organize think aloud data related 
to the question ‘were you tired’ for all patients per response category per assessment, 
including then-test. For the analysis, three authors (MW, AT, TH) each independently 
read the mind maps of each patient. They studied patients’ scores, their think 
aloud responses, and examined whether response shift type explanations would be 
provided: recalibration (i.e. using different standards of comparison to assess fatigue 
over time), reprioritization (i.e. changes in the importance attached to fatigue over 
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time) and reconceptualization (i.e. changes in the meaning of fatigue over time). 
Two researchers (MW, AT) searched for additional explanations in the core texts to 
account for the response behaviour and the discrepancies. The research team (MW, 
AT, TH, MS) discussed critically the different response strategies used by the patients 
and the robustness of the interpretations of response shift.
Patient Mary
Mary was 60 years old and married. She had two sons and two grandchildren. Her answer to the 
EORTC question was consistently ‘not at all’, except for the then-test concerning the interview T1. 
This suggests that she did not suffer from fatigue in the week prior to the interviews and that fatigue 
due to chemotherapy did not have any impact at all on her energy level. But, during the interview 
she spontaneously provided information that indicated that chemotherapy had an impact on her 
life and that she regularly suffered from fatigue.
T1 EORTC score ‘not at all’
Think aloud: Were you tired… no not at all, no, no difference compared to the past
Interview: I’m getting tired at the least little thing.
T2 EORTC score ‘not at all’
Think aloud T2: Not tired, last week, not at all
Think aloud then-test T1: A little, more than at the moment. 
Interview: According to the doctors, the X-rays were very good no. I’m very optimistic, 
sometimes I’m tired but that’s my own fault. I don’t have as much energy as I did before I 
became ill. 
T3 EORTC score ‘not at all’
Think aloud: Last week I wasn’t tired, it’s the second week after my chemo, not at all tired 
Think aloud then-test for T2: Not at all 
Interview: Yes, it was my last cycle of the chemo, I was afraid that I wasn’t going to be able 
to carry on through the treatment. But I managed, okay; I’m tired but apart from that… 
nothing at all.
T4 EORTC score ‘not at all’
Think aloud: No I wasn’t tired last week, not at all 
Think aloud then-test for T3: Not at all
Interview: Now and then, I’m tired. It’s different to before my chemotherapy. Sometimes I’m 
so tired, so tired, more than in the past. It comes suddenly…in the middle of the day. 
Box 1. Example of a patient with discrepancies in reported level of fatigue
Results
Patients with or without discrepancies
Of the 23 patients, 15 (5 male and 10 female, age 46-72) showed discrepancies at 
least at one measurement point, i.e. differences between their answer to the EORTC 
question ‘were you tired’ and their level of fatigue spontaneously reported during the 
interview. In their answers to the EORTC questionnaire they all presented themselves 
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positively and said that they were not tired. Mary, for example, was 60 years old at the 
time of the ﬁrst interview. During all her interviews she reported that she was tired, 
but she consistently answered ‘not at all’ to the EORTC question (Box 1). Only once 
she scored ‘a little bit’. This was at T2 when ﬁlling in her questionnaire as a then-test 
for T1 and she commented “a little, more than at the moment”.
Patient Ann
Ann was 47 years old and living with a partner. She didn’t have any children. Her scores 
suggest that the chemotherapy had a slight impact on her energy level during her treatment 
and a greater impact six weeks after completion of the treatment. But, the interview and the 
think aloud provided information that indicated that the chemotherapy had a growing impact 
on her life, and the score ‘quite a bit’ at T4 was the result of bad news ( i.e. a recurrence of 
the tumour). Furthermore, her data show examples of different response strategies, comparison 
with more sick patients and self-presentation.
T1 EORTC score ‘not at all’
Think aloud: Were you tired.. in principle I wasn’t tired. I was mentally tired, it costs me a 
lot of energy to talk with my relatives. I think you mean physically tired. You’re tired in 
the sense that you can hardly put one foot in front of the other. That’s being tired. No I’m 
not tired.
Interview: I want to be realistic, think positively. I try not to worry; there is nothing I can 
do. I don’t know when I will die. I get angry when people are surprised…if I say I’m doing 
ﬁne…it’s my decision how I’m feeling. 
T2 EORTC score ‘a little bit’
Think aloud: I feel it a little bit, compared to other people who are very sick. So, if I have 
pain or when I’m tired I say to myself don’t complain, so everything I feel, I only feel a 
little. I’m doing ﬁne. 
Think aloud then-test for T1: A little
Interview: Yesterday, I worked for three hours and I was exhausted. I went to bed in the 
middle of the day in order to be able to show my friend that I’m doing ﬁne. She has trouble 
in coping…me… having cancer.
T3 EORTC score ‘a little bit’
Think aloud: A little, yes because I have the feeling that I was able to get over it 
Think aloud then-test for T2: I think that I’ve said a little last time, it felt a little, but I shift 
my limit.
Interview: It’s a kind of tiredness, I don’t know. I’ve never been like that. To allow yourself to 
be tired. I think that the story they all tell, that the last cycle of chemo has the most impact, 
I think that’s very very true.
T4 EORTC score ‘quite a bit’
Think aloud: Yes, I was quite a bit tired, but only mentally tired. I have to adjust to the idea of 
a new course of treatment and radiation. My health is excellent. I’m able to do everything I 
like, better than six weeks ago. But, with all the medicine I’m taking to suppress the epileptic 
ﬁts… I’m scared, just like after the start of chemo. 
Think aloud then-test for T3: A little but I am not really sure, the pain which I had in my 
ankels made me tired.
Interview: The radiation will make me tired, but it has not started yet, so I am not tired yet. 
Box 2. Example of a patient using different response strategies, comparison with more sick 
patients, response shift and self-presentation.
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For many of our respondents, every new cycle of chemotherapy had a more severe 
impact on their energy level. Therefore, the highest level of fatigue was to be expected 
after the 5th and last cycle of chemotherapy, at T3. However, the 15 patients with 
discrepancies all answered the question ‘were you tired’ with ‘not at all’ or ‘a little’. 
For example, during her interviews at T2 and T3, Ann reported the growing impact 
of every cycle of chemotherapy, but her answer to the EORTC question at both 
interviews was ‘a little’(Box 2).
Think aloud about the question ‘were you tired’
I’m not tired all the time
I’m only tired in the afternoon
No not at all, I’m not tired at the moment, it comes suddenly
I have to be honest, sometimes I’m tired, I can’t say not at all, otherwise I would be lying
I’m not really tired, it’s something else
No not tired, it’s the ﬂue, that’s why I’m tired
It’s not being tired you know, it’s more like being restless
I’m not physically tired, I’m mentally tired
Actually, I can’t be tired because the Hb level in my blood is okay
I’ve no problems with it 
I’m currently doing nothing, so I’ve no problems, I’m not tired
Of course, you can make yourself tired, but I’ don’t
I can still cope with it; I don’t want to exaggerate
I’m a little bit tired but it’s due to something else
A little, but it was my own fault, I did too much
I didn’t have a proper meal, that’s why I was tired
I didn’t have my lady working for me in the house, she went on holiday
It’s because I’ve got problems with my voice caused by the radiation
Box 3. Examples of different response strategies used by patients with discrepancies (n=15)
Patients with discrepancies were identiﬁed in both stages of disease and with both 
treatment regimens, i.e. 12 patients (LD n=5, ED n=7) treated with chemotherapy 
and 3 LD patients treated with chemotherapy and radiotherapy. During the course 
of the treatment (T1-T4, 55 interviews) they answered the question ‘were you tired’ 
20 times with ‘not at all, 29 times with ‘a little’, 4 times with ‘quite a bit’ and twice 
with ‘very much’(see individual scores per interview in Table 1). 
No discrepancies were identiﬁed in 8 of the 23 patients (LD n=4, ED n=4, age 39-72). 
They answered the question ‘were you tired’ at the end of chemotherapy (T3) with 
‘quite a bit’ or ‘very much’. During the course of treatment (T1-T4, 28 interviews) 
these patients answered the question twice with ‘not at all’, 9 times with ‘a little’, 
11 times with ‘quite a bit’ and 6 times with ‘very much’ (Table 1). 
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Then-test scores were dissimilar with scores of the previous assessment in 25 out of 52 
cases, with higher then-test scores in 16 cases. Transcripts showed that patients had 
difﬁculty remembering either the previous measurement point and/or their fatigue 
at that time. 
Patients’ characteristics
Discrepancies M/F Age LD/ED T1 T1t T2 T2t T3 T3t T4
P 02 Male 57 ED 3 3 - - 1 - -
P 04 Female 50 LD 1 2 2 3 2 3 2
P 08 Female 69 ED 2 2 1 2 1 2 2
P 09 Male 66 ED 3 2 2 2 2 2 2
P 10 Male 46 LD 2 2 2 2 2 2 2
P 12 Female 47 LD 1 2 2 2 2 2 3
P 15 Female 69 LD 1 2 2 3 2 3 2
P 17 Female 64 ED 2 2 2 2 2 - -
P 18 Male 72 ED 1 1 2 - 1 - 3
P 21 Male 69 ED 2 2 2 3 2 2 2
p 22 Male 55 LD 4 1 1 - 2 - -
P 24 Female 56 LD 1 1 1 2 1 2 1
P 26 Female 59 LD 4 2 1 2 2 - -
P 32 Female 60 LD 1 2 1 1 1 1 1
P 34 Female 51 LD 1 1 2 1 2 1 1
No discrepancies
P 01 Female 42 LD 2 2 - - 4 4 3
P 03 Female 64 ED 3 1 - - 3 3 4
P 13 Male 72 ED 3 3 2 3 3 2
P 14 Male 39 LD 4 3 2 2 3 - -
P 16 Male 68 LD 1 1 3 3 3 3 2
P 20 Female 44 LD 1 - 4 - 4 - 4
P 27 Male 69 LD 3 2 2 - - 4 2
P 29 Male 63 ED 2 3 3 2 3 3 2
Table 1. Individual (then-test)scores of patients answering the EORTC QLQ-C30 question ‘were 
you tired’. Response categories 1, 2, 3 and 4 are representing respectively the category ‘not at all’, 
‘a little’, ‘quite a bit’ and ‘very much’. Small-cell lung cancer patients (n=23), limited (LD) and 
extensive (ED) disease receiving 1st line chemotherapy were interviewed at equivalent points in 
treatment: at start of chemotherapy (T1), 4 weeks later (T2), at end of chemotherapy (T3), and 6 
weeks later (T4). T1t, T2t and T3t are representing then-test scores obtained at respectively T2, T3 
and T4, when patients are asked to provide a renewed evaluation of their fatigue at the previous 
assessment. Two groups were identiﬁed: patients with (n=15) and without (n=8) discrepancies 
between their questionnaire answer and fatigue spontaneously reported in the interview.
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Response strategies for the four response options
The think aloud texts for the response categories ‘quite a bit’ and ‘very much’ were 
minimal in the entire study population. Only a few patients reacted brieﬂy during the 
think aloud, e.g. “quite a bit, too tired to keep my eyes open”, “yes quite a bit, very tired”
and “next week it will be better…very much”. The same pattern was found in all patients 
for all four response options when ﬁlling in the questionnaire as a then-test, e.g. ”a
little bit, I think”, “tired then, no” and “very much”. However, patients in the group with 
discrepancies had much more to say in the conventional QoL measurement when 
choosing the options ‘not at all’ and ‘a little’. During ‘think aloud’, they seemed to 
justify the chosen response category. They used various strategies to moderate the 
impact of fatigue on their life. We summarized their strategies in four categories: 1) 
I am not tired all the time (e.g. “only in the afternoon”); 2) I am not really tired, it’s 
something else (e.g. ” it‘s the ﬂu”); 3) I have no problems with it (e.g. “I can still cope 
with it; I don’t want to exaggerate”); 4) I am a little bit tired but it is due to something 
else (e.g. “I didn’t have a proper meal”).
Many of our respondents said that they had expected to become very tired as a result 
of the treatment, but that they were not as sick as they had expected. They were 
very happy that they were able to cope with the treatment, and had adjusted to the 
situation. A male patient, for example, had a score of ‘not at all’ at T2, and explained: 
“I’m currently doing nothing, so I’m not tired”. The respondents indicated that they 
wanted to be honest when ﬁlling in the questionnaire and did not want to lie or to 
exaggerate their fatigue and, because many patients were not tired all the time they 
considered a score of ‘not at all’ or ‘a little’ to be a suitable score. 
Optimism
Most patients told the interviewer regularly that they had adapted to the situation 
and had changed their attitude towards a more optimistic perspective. They were not 
hopeful immediately after diagnosis, but optimism about recovery increased when 
the tumour was shrinking. Of the 23 patients 17 reported spontaneously that they 
were optimistic: e.g. “I’ve got good news, I’m as optimistic as can be”, “I’m full of hope 
because I was diagnosed in an early stage, so I’m good in time”. Furthermore, they said 
that they felt better off than expected, compared to patients who were worse off e.g. 
“I’m lucky not to be very sick, compared to the patients I saw at the hospital”. Although 
they experienced the impact of every new cycle of treatment as more severe, they said 
to be able to cope with the treatment and to accept the side-effects: e.g. “it’s part of 
the package, I’m willing to put up with, knowing the chemo is doing the job properly”. Some 
patients were actually feeling better after each cycle and happy that they were still 
alive: e.g. “It was much worse than I wanted to admit last time, I’m feeling much better”,
“I’ve already a couple of months extra”.
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In contrast, 5 of the 23 patients expressed pessimistic feelings: e.g. “I’m a broken man, 
hard work all my life and now…I don’t think I’ve much time left”, “I’m a bit depressed, when 
does it stop, if it doesn’t stop it would be better if my life was over”, “No plans for the future, 
you never know when the tumour will come back”. These patients all reported high levels 
of fatigue during the course of the treatment. One patient did not provide speciﬁc 
comments about optimism or pessimism.
Spontaneously reported coping behaviour
Protective behaviour
I’m trying to avoid or minimize pessimistic thoughts
I don’t think about it, otherwise I can’t cope with it
We don’t talk about it, just follow my every day routine
 I’m building a wall around myself
Assertive behaviour / power display
I’ll show others that I’m managing all right
You have to be positive
You have to believe in yourself, otherwise you can’t manage it anymore
Fighting the stigma
I’m not the cancer patient my neighbour thinks I am
They think I’m lying on my bed all day
People look at me, and give advice that I don’t want
I have to admit that I really am a cancer patient… I didn’t want to be (see patient Ann, Box 2).
Box 4. Examples of coping strategies used by patients with discrepancies (n=15)
Response shift and self presentation 
In both groups – with and without discrepancies - we found patients who had 
reported to have changed their reference point after T1 (i.e. recalibration in contrast 
to T1). They compared their fatigue at the second and following interviews with 
that of other patients (e.g. “I was tired, yes, but compared to the patients I’ve seen in the 
hospital, I’m just a little bit tired”) or, with the period in which they were more tired 
(e.g. “Compared to the ﬁrst week after chemo, it’s the second now … I’m not tired ”). In one 
case, a patient spontaneously re-evaluated her previous measurement: “I told you that 
I was really tired then, but compared to how I’m feeling now, it was then just a piece of a 
cake”. Another one spoke about a shift of limits which also suggests recalibration: “I
already told you that I would change my standards”.
We did not ﬁnd indications of reconceptualization and reprioritization of fatigue. 
The only exception was Ann who made a distinction between being physically 
and mentally tired (see Box 2). At T1, she said that she was mentally tired but not 
physically and her answer was ‘not at all’: “Tired means that you can hardly put one 
foot in front of the other”. At T4, she said that she had recovered from chemotherapy 
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and was physically able to do anything she wanted but, unfortunately, suffered 
from sudden epileptic attacks caused by metastases. She was feeling anxious in the 
same way as at the start of her chemotherapy, and had to consider further treatment 
options. Just like in the interview at T1, she said that she was mentally tired but 
not physically. However, this time her score was ‘quite a bit’ instead of ‘not at all’: 
“Purely, because I was mentally tired last week. I have to adjust to the idea of a new course 
of treatment. Actually, I have to admit that I really am the cancer patient I never wanted to 
be ”. This response pattern might be interpreted as reprioritization (i.e., changes in 
the importance attached to mental fatigue over time).
Because the above mentioned response shift type explanations could not adequately 
explain our conﬂicting ﬁndings in the discrepancy group we questioned: “Why are 
patients presenting themselves in the questionnaire more positively than in the 
informal interview”. In our search for an other explanation, we found that 13 of 
the 15 patients with discrepancies had spontaneously reported how they dealt with 
having cancer and the perspective of a short life-expectancy. We summarized their 
comments in three categories (see examples of coping strategies in Box 4): 1) Protective 
behaviour (e.g. protecting themselves from harmful thoughts); 2) Assertive behaviour/
power display (e.g. projecting the image of being positive and managing all right); 3) 
Fighting the stigma (e.g. ﬁghting against being stigmatized). 
Taking these strategies into account, we concluded that a possible mechanism 
underlying the discrepancies in this group was ‘self-presentation’. As the questionnaires 
are explicitly related to cancer and since these patients want to distance themselves 
from being reduced to only a cancer patient, they want to present themselves as a 
person who just happened to have cancer. Therefore, they applied various strategies to 
respond to the question on fatigue in order to produce a score that was as favourable 
as possible and presented themselves as positive and managing their fatigue.
Discussion
Two third of the patients showed discrepancies in their reported level of fatigue. They 
reported a gradual decrease in energy at the end of chemotherapy, but they were ‘not 
at all’ or just ‘a little bit’ tired according to their answer to the EORTC questionnaire, 
with ‘underreporting’ as a result. They presented a positive image of themselves and 
used various strategies to explain their choice of response category. A predominant 
ﬁnding was that patients adopted a more optimistic perspective on the treatment. 
Interestingly, this was not exclusively found in the discrepancy group. The same was 
true for recalibration and for the only indication of reprioritization. These response 
shift type explanations did not sufﬁciently account for the conﬂicting ﬁndings in our 
discrepancy group. 
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Self-presentation was found to be an additional (coping) mechanism underlying 
the discrepancies. Our results suggest that patients are not only concerned about 
the impression they make on others. They try to protect themselves from negative 
thoughts and they also feel the need to be positive and to distance themselves from 
the stereotypical cancer patient. With this strategy they are more capable of coping 
with a situation that they cannot change. 
The suggestion that self-presentation is an underlying mechanism is supported, for 
example in the case of Ann. She told us that after a recurrence of the tumour she 
adopted the realistic perspective by admitting that she really was ‘the cancer patient’, 
which she did not want to be before. It seems that she gave up her attitude of showing 
others that everything was all right, and for the ﬁrst time she did not present her self 
as more positive than she actually was as she did before. 
Self-presentation (also called impression management 16-17 ) is a phenomenon described 
by Leary et al. in relation to health behaviour. 18 They discussed its implications for 
research in health psychology. Our study shows that, in addition to response shift, self-
presentation may explain unexpected results, at least in SCLC patients. The question 
‘were you tired’ in the EORTC-QLQ-C30 does not unequivocally measure the impact 
of chemotherapy on the energy level of patients; in fact, with their responses, patients 
seem to show how that they are managing the situation. From our results we cannot 
conclude that in the group without discrepancies ‘self-presentation’ is not present 
at all, or that whenever self-presentation occurs discrepancies will also be present. 
However, our study does show that ‘self-presentation’ affects QoL measurement. 
These ﬁndings must be taken into account when investigating and interpreting QoL 
data, also in other study populations. Especially after diagnosis and in the initial 
phase of treatment, ‘self-presentation’ might be an important coping strategy. In fact, 
during each phase in which a new equilibrium and a new identity has to be found 
(e.g. after a recurrence of the tumour, or metastases) self-presentation might affect 
QoL measurement.
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Abstract
Background
Quality-of-life (QoL) is considered to be an indispensable outcome measure of curative 
and palliative treatment, but QoL research frequently seems to produce counter-intuitive 
ﬁndings. Occasionally, the expected deterioration in QoL is not reported, and intra-
individual comparisons over time do not seem to be sensitive to change. 
Objective
To investigate how patients interpret and respond to questions on the EORTC-QLQ-
C30 over time, and to ﬁnd explanations to account for counter-intuitive ﬁndings in 
QoL measurement.
Methods
Qualitative investigation of the response behaviour of small-cell lung cancer patients 
(n=23) in the measurement of physical and role functioning with the European 
Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire 
(EORTC QLQ-C30). Interviews were held at four points during 1st line chemotherapy: 
at the start of the chemotherapy, 4 weeks later, at the end, and 6 weeks after the 
end of the chemotherapy. Patients were asked to ‘think aloud’ when ﬁlling in the 
questionnaire.
Results
The patients used various response strategies when answering questions about 
problems and limitations in functioning. By taking the wording of questions literally, 
by guessing their functioning in activities which they did not perform, and by 
ignoring or excluding certain activities which they could not perform, the patients 
had scores suggesting that they were less limited than they actually were. 
Conclusion
Terminally ill patients evaluate their functioning in terms of what they perceive to 
be normal under the circumstances. Their answers can be interpreted best in terms of 
response behaviour, which had been described by Rapkin & Schwartz. Change in the 
appraisal of QoL explains how levels of physical and role functioning are sustained 
under deteriorating physical health. 
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Introduction
Quality-of-life (QoL) is considered to be an important outcome measure of 
curative treatment, but it is particularly relevant for cancer patients, who receive 
life-prolonging and ‘palliative’ therapy. Not only the assessment of the burden of 
symptoms and psychological well-being, but also the assessment of global QoL and 
physical and role limitations is considered to be important in the evaluation of 
medical and psychosocial interventions. However, QoL research frequently seems 
to produce results which are not very consistent. For example, discrepancies have 
been found between objective and self-rating of health; patients with a chronic 
disease have been found to report levels of QoL that are equivalent to those of 
healthy controls, and other patients have rated their QoL better than their caregivers 
assessment.1-4 Such ﬁndings, explained as ‘underreporting’ by Breetvelt & Van 
Dam5, suggest that patients report less emotional distress and dissatisfaction than 
they actually experience, and that intra-individual comparisons over time may not 
be sensitive to change. 
The results of other longitudinal studies also illustrate the problems that are 
encountered in the interpretation of QoL outcomes. The European Organization for 
Research and Treatment of Cancer Core Quality of Life Questionnaire EORTC (EORTC 
QLQ-C30) is designed to measure the physical, psychological and social functioning 
of cancer patients.6;7 This instrument was found to be useful, for example, to evaluate 
the effect of palliative treatment with radiotherapy8; but it was found that the role 
functioning scale was not reliable at all. Groen et al.9 measured QoL with the EORTC 
questionnaire in patients with inoperable non-small-cell lung cancer treated by 
radiation with and without chemotherapy. They found no signiﬁcant change in QoL 
between pre-treatment and on-treatment, despite an observable increase in the side-
effects of treatment with radiotherapy. Furthermore, Cox10 studied cancer patients 
who participated in a clinical trial; she found no signiﬁcant change in the EORTC 
assessment, but the in-depth interviews led to alternative conclusions about the 
impact of the trial on these patients. 
In recent years the response shift theory11, which refers to a change in internal 
standards, values and conceptualization of QoL, has gained increasing attention in 
explaining counter-intuitive and paradoxical ﬁndings. Therefore, we investigated 
response shift in QoL measurement in small-cell lung cancer (SCLC) patients during 
1st line chemotherapy. We were also interested in other explanations for counter-
intuitive ﬁndings, and we therefore wanted to ﬁnd out how patients actually dealt 
with QoL questions. Recently12 we reported the discrepancies we found between 
the levels of fatigue measured with the questionnaire and the levels spontaneously 
reported during the interview. In addition to the discrepancies we found, we were also 
surprised by the way in which these patients interpreted the questions about global 
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QoL and physical and role functioning, and produced scores suggesting that they 
were less limited than they actually were. We therefore investigated their answers to 
these questions in more depth.
This paper describes the results of an exploratory longitudinal multiple case study in 
which we investigated how patients interpret and respond to questions on the EORTC-
QLQ-C30 over time. We focused on global health and global QoL (GH/QOL) and items 
on the physical and role functioning scales. We aimed to search for explanations to 
account for counter-intuitive ﬁndings in QoL measurement. 
Methods
Procedures and study sample 
In 2000, approval was obtained from the Medical Ethics Committee of the VU 
University Medical Center for our study ‘Response shift in quality of life in the 
palliative treatment of small-cell lung cancer patients’. In March 2001 we started to 
recruit SCLC patients in ﬁve outpatient clinics for chest diseases in the Netherlands. 
All patients were evaluated for 1st line chemotherapy and no restrictions were made 
with regard to age or treatment (chemotherapy or a combination of chemotherapy 
and radiotherapy). The participating patients gave written informed consent and were 
interviewed during the treatment trajectory. The ﬁrst interview (T1) was carried out 
at within 7-10 days after diagnosis at the start of the chemotherapy. In the original 
study design the second interview was planned after completion of the course of 
chemotherapy. However, after the inclusion and ﬁrst interviews with 3 patients we 
decided that we would also interview the patients during the treatment. Therefore, 
the second interview (T2) was held four weeks after T1, the third (T3) 7-10 days after 
completion of the chemotherapy treatment, and the fourth (T4) six weeks later. 
Between March 2001 and September 2003, 41 eligible patients were invited to participate 
the study. Four patients were unwilling to participate and 6 were not interviewed because 
of their imminent death. Of the 31 patients who were interviewed, 8 were excluded 
from the analysis because their data were incomplete, i.e. they were only interviewed 
once (six died within a month after T1 and two were too sick at T2 and died before the 
end of the planned chemotherapy). Consequently, the ﬁnal study sample consisted 
of 23 SCLC patients, 12 of whom were diagnosed with limited disease (3 male and 9 
female, mean age 55, range 42-69) and 11 with extensive disease (8 male and 3 female, 
mean age 64, range 39-72). Except for 7 patients whose chemotherapy was combined 
with local radiation of the tumour, all patients received standard chemotherapy. The 
majority of the patients were married (19, 83%), and had children (17, 74%). 
Of the 23 patients in our study sample, 15 were interviewed four times, 7 were 
interviewed three times, and one patient was only interviewed twice resulting in a 
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total of 83 interviews. The interviews were conducted by MW and had an average 
duration of 80-110 min. Except for the ﬁrst interview with 3 patients, all interviews 
were held in the patient’s home. 
Materials and qualitative method 
In this exploratory, longitudinal multiple-case study, QoL was assessed with the EORTC 
QLQ-C30 (version 3.0)7 and the lung cancer module QLQ-CL13.13 The EORTC QLQ-
C30 is the cancer-speciﬁc QoL measurement instrument that is most widely used in 
European clinical trials. The questionnaire consists of several functioning scales which 
measure, among other things, physical and role functioning, mental and general 
health, and global QoL. Furthermore, it measures different symptoms such as pain, 
dyspnoea, nausea and fatigue. For the questions about functioning the respondent has 
four response options. The respondent circles the most appropriate number, i.e. 1) not 
at all, 2) a little, 3) quite a bit and 4) very much. Furthermore, general health and global 
QoL are rated by circling a number between 1 and 7 (respectively from very poor to 
excellent). The QLQ-CL13 module measures the extent to which patients experience 
symptoms or problems related to their lung cancer, such as coughing and hair-loss.
The EORTC QLQ-C30 and the CL13 were completed in combination with the Three-
Step Test-Interview (TSTI) to investigate how respondents interpreted the items and 
how they responded to them. The TSTI consists of the following steps14 : 1) concurrent 
think aloud, aimed at collecting observational data on how respondents complete 
the questionnaire, expressing their thoughts aloud; 2) focused interview, aimed 
at clarifying the respondent’s previous expression of thoughts while completing 
the questionnaire; 3) semi-structured interview, aimed at eliciting the respondent’s 
experiences and opinions with regard to the questionnaire. 
Interview protocol
Each interview was conducted in an identical format. At T1, QoL was measured 
with the EORTC QLQ-C30, followed by the lung cancer module QLQ-CL13. The 
questionnaires were completed in a concurrent think aloud manner, and after 
completion the respondents were asked to clarify previous hesitations, expressions 
when rating certain items and experiences (i.e. second and third step of the TSTI). 
Individual QoL was then measured with the Schedule for the Evaluation of Individual 
Quality of Life – Direct Weighting (SEIQoL-DW).15;16 Finally, we encouraged patients 
to talk freely about their experiences with the treatment. At follow-up (i.e. T2, T3 and 
T4), after the SEIQoL-DW assessment, EORTC questionnaires were completed again as 
a so-called ‘then-test’17-19 (i.e. the patients ﬁlled in these questionnaires according to 
how they perceived themselves at the time of the previous interview). In the second 
and following interviews, EORTC questionnaires were completed in a concurrent think 
aloud manner, and with the second step of the TSTI integrated in the assessment. We 
encouraged patients to think aloud and we probed for clariﬁcation after each item 
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if extra information was considered to be useful in order to understand the patient’s 
answers. We adopted a ﬂexible approach in order not to interrupt the natural ﬂow of 
both the assessment and the patient-interviewer communication. 
The interviews were audio-taped and transcribed verbatim. In this article we focus on 
the physical functioning scale (PF, items 1 to 5), the role functioning scale (RF, items 
6 and 7) and global health and QoL rating (GH/QOL, items 29 and 30).
Analysis
Four types of data were collected and used for the analysis20: 1) completed question-
naires (T1 t/m T4), 2) observed patient behaviour recorded in ﬁeld notes, 3) tran-
scriptions of the interviews, and 4) memos with background information regarding 
the illness trajectory of each patient. Firstly, three authors (MW, AT, TH) independently 
analysed the ﬁrst two interviews and questionnaires completed by the ﬁrst patient. 
This analysis included all questions on both of the EORTC questionnaires, and the 
aim was to understand why a speciﬁc response category was chosen, and to identify 
change in the response behaviour by comparing the results of the two interviews. 
The results of our measurement of response shift with the SEIQoL-DW will reported 
elsewhere.21
In our further analyses of all the interviews (n=83) concerning GH/QOL, PF and RF, 
we used the qualitative computer package Kwalitan 5.0 (http://www.kwalitan.net) to 
extract relevant parts of the transcriptions: 1) think aloud of the GH/QOL questions 
and the functioning scales (i.e. physical and role) and 2) ‘comments’ related to the 
way in which patients were functioning, and the perceived impact of treatment 
on QoL. Furthermore, in order to deal with the still remaining large amount of 
extracted data, two of the authors (MW, AT) condensed extracts from transcripts of 
the ‘comments’ into core texts. The data were analysed for each patient separately, 
resulting in 23 case-studies.22 For each case the data (i.e. think aloud combined with 
scores and core texts of comments) were organized per interview in one mindmap 
by means of the computer package Mindjet Mindmanager Pro 6 (http://www.
mindjet.com) (see for an example of organizing data by means of a mindmap our 
article on the EORTC question ‘were you tired’).12 For the further analysis, MW read 
the mindmaps of each patient and investigated how the patient had answered each 
item (i.e. interpretation of the question, response, and choice of response category). 
She interpreted the individual score and the think aloud data of that item against 
the background of the patient’s illness trajectory, and assessed whether that item 
had received a score that one would expect if it truly reﬂected the limitations the 
patient experienced. Finally she looked for change in the item appraisal process 
over time. After completing the individual cases, MW and AT searched for patterns 
in the response strategies for each item by examining similarities and differences 
between the cases. The robustness of their interpretations was critically discussed by 
the research team (MW, AT, TH, MS). 
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Results
Quality of Life during ﬁrst-line chemotherapy
For all the patients chemotherapy consisted of 5 cycles. After the ﬁrst cycle (T2), 13 
of the 19 patients said that they were doing well, considering the circumstances. 
Patients diagnosed with extensive disease who suffered from tumour-related 
symptoms, such as dyspnoea and coughing, even felt much better than before the 
treatment. Furthermore, 3 of the 7 patients who had been treated with chemotherapy 
and radiotherapy, experienced the severe physical burden of the side-effects of 
radiotherapy (e.g. pain, problems with eating and drinking, and consequent loss of 
weight). All the patients experienced the impact of every new cycle as more and more 
severe. Six weeks after the last cycle, 3 patients had died and 2 were confronted with 
a recurrence of the cancer and further treatment. The others tried to pick up their 
normal life again. 
According to the results of the EORTC-QLQ-C30, QoL was affected very little by the 
chemotherapy (Table 1). The mean values for GH/QOL at the start (T1) and at the end 
of the chemotherapy (T3) were both 66. The mean value of the physical functioning 
scale decreased from 75 at T1 to 72 at T3, but the mean value of role functioning 
increased from 62 at T1 to 72 at T3; 7 patients had the highest possible rating (100) 
and only 1 patient had the lowest possible rating (0). 
We were not able to interview all 23 patients 4 times, and therefore the mean values 
presented for T2 and T4 can not be adequately compared with the mean values for T1 
and T3. However, despite these differences and the large individual variations, most 
of the patients perceived their QoL to be at a higher level at T2 than at T1 (start of 
chemotherapy): 12 of the 19 patients reported a higher level, 2 an equal level, and 5 
a lower level of GH/QOL. The patients also reported better QoL at T4 (six weeks after 
the course) than at T3 (end of the course): 10 of the 18 patients reported a higher 
level, 4 an equal level, and 4 a lower level of GH/QOL. With respect to the functional 
scales, the mean values of physical and role functioning also increased six weeks after 
the course, suggesting that most patients no longer had any limitations: 8 of the 18 
patients reported the highest level (100) of role functioning, and only 1 patient the 
lowest possible rating (0). In order to understand how the QoL outcomes in our study 
should be interpreted, background knowledge of the response behaviour described 
below has to be taken into consideration.
Patients’ answers at the ﬁrst QoL assessment
From the questions about physical and role functioning (questions 1 to 7) the researcher 
can detect the degree of problems or limitations a patient experiences during certain 
activities. However, the patients responded in unexpected ways: by focusing on one 
aspect of the question, by taking the wording of the question literally, by ignoring 
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or excluding certain activities which they could not perform;the patients produced 
scores suggesting that they were less limited than they actually were (see Figure 1 for 
examples). Furthermore, a few patients guessed their level of functioning in activities 
which they did not perform or used the strategy “I didn’t do it, so I don’t have any 
trouble” (example see item 2), and other patients compared present with previous 
experiences (e.g. “I feel not too bad, compared to last week”), or with expectations (e.g. 
“I feel better as expected”).The following examples illustrate for each question how, 
during the ﬁrst interview (T1), a certain strategy resulted in a different score than 
would objectively be expected. 
Item 1: Do you have any trouble doing strenuous activities, like carrying a heavy shopping 
bag or suitcase?
A patient who could hardly walk outside the house answered this question with ‘not 
at all’ by arguing that you can’t have any trouble if you don’t do any shopping: “I 
never carry a shopping bag, my wife does the shopping” [M, age 72, T1]. At T1, 17 out 
of the 23 patients interpreted this item more or less literally, and focused on just 
shopping bags or suitcases: “I can lift the shopping bag but I can’t walk with it” or “my
suitcase has wheels, so I don’t have to carry it”. Out of the other 6 patients, 4 were 
thinking about other streneous activities when evaluating this item, and 2 were just 
circling the number which corresponded with ‘a little’ and explained that they had 
already been limited for a longer time. It seemed that they were therefore suggesting 
that their limitations were considered as ‘normal’.
Item 2: Do you have any trouble taking a long walk?
For many patients this question was difﬁcult to answer, because they had not had 
long walks during the previous weeks. Of the 23 patients, 11 ﬁrst struggled with the 
deﬁnition of ‘long’ (which differed from 10 minutes to 2 hours or from 500 metres to 
10 kilometres) and then they tried to guess their limitations: “What is a long walk, 5 
kilometres…? I never go for a long walk, I don’t like serious walking,, but I think I would be 
limited…. a little?” [M, age 68, T1]. The other 12 mentioned a recent walking experience, 
and most of them tried to guess: “I haven’t had a walk in the past weeks, so I don’t know, 
but I walked with my son through the corridors in the hospital and that went ﬁne. So, I haven’t 
tried …a little?” [F, age 69, T1], and 2 used the same strategy as mentioned earlier (i.e. I 
didn’t walk, so I don’t have any trouble).
Item 3: Do you have any trouble taking a short walk outside of the house?
Most patients seemed to have an image of a short walk in their mind, and circled without 
hesitation a response category. Others remembered a recent experience: “A little, I’ve been 
to the shops at the end of the street and that was enough for me” [F, age 64, T1].
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Item 4: Do you need to stay in bed or a chair during the day?
Many patients answered this question by laying the stress on one word in particular. 
This resulted in higher levels of functioning than would be expected. For example, 
7 out of the 23 patients took the word ‘need’ very seriously and did not report any 
limitation because ”it’s not really necessary to stay in bed or on a chair”. Another patient 
interpreted the word ‘need’ as being prescribed by the doctor. Because he did not 
have such a prescription, his answer was ‘not at all’, even though he spent most of 
the day in his bed [M, age 71, T1]. Another 6 patients interpreted this question with 
an emphasis on staying in bed, which they did not do during the day. Although these 
patients said that they took a nap or a rest on a regular basis, they did not take sitting 
on a chair into account. The other half of the patients did not comment on this item, 
but just circled the response category of their choice.
Item 5: Do you need help with eating, dressing, washing yourself or using the toilet?
One older male patient considered the help which he received with washing and 
dressing as normal under the circumstances, and said: “No not at all, I can do it by 
myself if I want to, I don’t really need help, but at the moment I have less energy and help 
from my wife makes it easier for me”[M, age 72, T1]. Only two patients needed help 
with eating, dressing, washing and using the toilet: all the other patients circled the 
response category of their choice without further comments, or saying that it was 
self-evident that they were not limited.
Item 6: Were you limited in doing either your work or other daily activities?
Most of the retired male patients (n=6) answered with ‘a little’ or ‘not at all’, arguing 
that they were not working anymore and therefore not limited. All female patients 
who did not have a job (n=8) reported during the ﬁrst interview the limitations they 
experienced in housework. The other 9 who worked had taken sick leave, and only 3 
of them (i.e. two male patients with their own business and one female patient with 
a part-time job) were actually thinking about their job and reported limitations. The 
other 6 acted differently, and ignored their work and focused on activities in and 
around the house: “I can do some work in the house, like sweeping the ﬂoor, so I’m not 
limited” [M, age 46, T1]. It seems that they considered not working as normal under 
the circumstances.
Item 7: Were you limited in pursuing your hobbies or other leisure time activities?
During the ﬁrst interview this question was answered with ‘very much’ in some cases 
when pursuing hobbies was not possible: “I always played billiards with my friends. 
I could play at the moment but I don’t, because then I’ll drink a couple of beers and that’s 
not a good idea now” [M, age 39, T1]. Other patients reasoned as mentioned earlier (i.e. 
I didn’t do it, so I’m not limited) : “I’ve not played the piano in the past few weeks…no, 
not at all” [M, age 68, T1]. The answer suggests that the patient is feeling physically 
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able to play, but that he does not take into account the fact that his illness might be 
the reason for not playing.
Item 26: How would you rate your overall health during the past week?
Item 27: How would you rate your overall quality of life during the past week? 
Most patients circled a number between 1 and 7 without much thinking aloud, and 
therefore after they had completed these two questions the interviewer asked them 
how they interpreted the questions. Most patients deﬁned overall health as how they 
were actually feeling: “Overall health…, you’re not a healthy person of course. Well 
it’s simple, you’re terminally ill, but you’re not really feeling sick so … a 5” [M, age 39 
at T1]. In evaluating overall quality of life, a few patients had just circled a number 
which they thought appropriate, without knowing what QoL meant. Most patients 
deﬁned overall quality of life as being able to do the things they want to do: “I can’t 
do things as usual, watching television, reading my paper and going to the bookshop. 
Walking at this moment is not possible … a 4” [M, age 72 at T1].
Figure 1. Examples of response strategies used to answer question 1, 2, 4, 6 and 7 of the EORTC-
QLQC30 questionnaire. These strategies and change in the use of a certain strategy over time 
may explain why patients do not report the deterioration in physical and role functioning that 
would objectively expected.
Change in patients’ answers
The variation in the interpretation and evaluation of the different items described 
above was not only found between patients, but also in the individual patient over 
time. Change occurred especially in the sampling of experiences when evaluating 
problems and limitations concerning items 2, 6 and 7. These changes sometimes 
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resulted in scores suggesting that a patient was functioning better than actually was 
the case, but we saw the opposite as well. For example, Nina (age 69) changed her 
interpretation of a long walk (item 2) by adjusting the distance. Her answer can also 
be interpreted as evidence of response shift, i.e. a change in standards. Her scores 
reﬂect an equal level of functioning, but she actually had less trouble in going for a 
walk at T4 than at T2. This improvement was not reﬂected in her scores:
[T2] That’s very difﬁcult, to the shopping mall, 450 metres, quite a bit. 
[T4] A long walk, two kilometres, I walk too fast, it’s my own fault, quite a bit.
Recalling different experiences over time suggested that there was a change in the 
patients’ perspective on “what was considered as normal under the circumstances” 
was changed. For example, Ralph, age 46, ignored his job (item 6), suggesting that 
taking sick leave was normal. Six weeks after the course he was actually less limited 
than during the treatment, but no longer ignored his job. That is why his improvement 
in role functioning was not reﬂected in his scores: 
[T2] A little, it depends how I’m feeling. If I have a good day, I can take on the whole world. 
Vacuum cleaning, my motorbike, my car”
[T4] A little, the ﬁrst day back at work again, the tension having to tell everyone the same 
story over and over again, but of course I feel much better than I did six weeks ago.
Another example shows how high levels of functioning are scored, while the patients 
were actually not functioning any better at all. Like most patients, John (age 69) felt 
very limited at T1 in pursuing his hobbies, but in his next interview these limitations/
were no longer mentioned.
[T1] “My hobby is working in the garden, that’s very difﬁcult, quite a bit”.
[T2] “I’m reading at the moment. Gardening is not possible anymore, a little”.
We found no evidence of change in the patients’ deﬁnition of overall health. Overall 
health was consistently interpreted as “how I’m feeling” (e.g. “Yes, you can’t miss it. 
My health is a 7, it feels like a 7” [ F, age 57, T2]. Neither did we ﬁnd any change in the 
interpretation of overall quality of life (i.e. “being able to do the things I want to do”), 
even in the case of a reoccurence of the cancer and brain metastases (e.g. “it depends on my 
contacts…that I can do my own things… a 5 is to low … it has to be a 6” [F, age 47, T4].
Discussion
The mean values of GH/QOL, physical and role functioning scales during the treatment 
trajectory suggest that the SCLC patients were functioning without many limitations 
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and had a good QOL. Actually these outcomes conﬁrm what was already known from 
the studies mentioned earlier, and demonstrate the need to investigate more in depth 
what is actually happening in QOL measurement. A predominant ﬁnding was that 
the patients evaluated the items concerning functioning against a standard of what 
they perceived as normal under the circumstances. This standard changed when the 
circumstances and their health changed. Furthermore, our results also suggest that 
the patients redeﬁned what is important and what is no longer important (e.g. work 
or hobbies which used to be important before the diagnosis). These ﬁndings suggest 
the occurrence of response shifts during the illness trajectory. 
Observing the QoL self-assessment by means of the think aloud procedure has 
provided us with insight into the black box of what actually happens in repeated QOL 
measurement. We have lifted the lid just for a little while by listening to the patient 
who is ﬁlling in the questionnaire.The physical and role functioning items appeared 
to be multi-interpretable, and therefore enabled a patient to give the impression of 
performing well under the circumstances. Just by ignoring certain activities which 
are mentioned in a question, or by taking a question literally, patients are able to 
maintain reasonable levels of functioning, if we are to believe the EORTC data. 
Through this behaviour looks it seems that, at a subconscious level, the patients are 
distancing themselves from the meaning behind the question, i.e. measuring the 
impact of treatment and disease on their functioning. If this is the case, the patients 
are presenting their situation more positively than it actually is. Previously12 we found 
that, in addition to the response shift phenomena, self-presentation is also a coping 
mechanism that can explain discrepancies in the measurement of fatigue. The aim of 
this study was not to investigate whether patients present a more positive image of 
themselves than they experience in their day-to-day life, but was predominantly to 
observe how patients interpret and answer the questions, and whether they change 
their way of answering. We found that the patients did not deal with the questions 
in the way that the researchers had probably intended. At face value, some questions 
were also found to be unimportant, not applicable to the patients’ situation, or 
not relevant at a certain point in time. These ﬁndings are in line with Mallinson’s 
suggestion that problems may arise when response options do not quite ﬁt the 
questions, because there are no such response options as ‘I don’t do this’ or ‘I don’t 
know’.23 On the other hand, the answers of patients who used the strategy ‘I can’t do 
this anymore, so I’m not limited’ can also be interpreted as evidence of response shift, 
i.e. reprioritization. Patients make good and legitimate use of the opportunity the QOL 
instrument provides to adjust the question to their own situation, and consequently 
present an image of not being as limited in functioning as one would expect. 
Our ﬁndings conﬁrm what has been stated by Rapkin and Schwartz24, who acknow-
ledge that counter-intuitive ﬁndings might be explained by change in the appraisal 
process: “QOL assessment induces a frame of reference which depends upon the 
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meanings the individual attaches to questions; in order to respond to any item, 
individuals necessarily sample speciﬁc experiences within their frame of reference, and 
each sampled experience is judged against relevant, subjective standards of comparison,
and to arrive at a QOL score, individuals must apply some combinatory algorithm
to summarize their evaluation of relevant experiences and formulate a response”. 
Changes in the perspective of SCLC patients during their treatment trajectory, change 
in their sampling of experiences when evaluating an item, and in their use of standards 
of comparison, explain the variance in QOL measurement at the individual level. 
Rapkin and Schwartz propose a psychometric model of appraisal, which questions 
the existing methods for establishing the reliability and validity of QOL assessment 
tools, and they recommend that the assessment of appraisal should be integrated 
into QOL research and clinical practice. The results of our study show that knowledge 
about how patients change their interpretation of questions is useful in interpreting 
QOL data. Therefore, we agree with Rapkin and Schwartz, that research is needed to 
learn more about the appraisal process. 
Conclusion
Terminally ill patients evaluate their QOL under the prevailing circumstances. 
Changes in the appraisal process, due to differences in the frame of reference, the 
sampling of speciﬁc experiences and the standards of comparison used when rating 
items, explain how reported levels of physical and role functioning and QOL are 
sustained under deteriorating physical conditions. Background knowledge about the 
illness trajectory and appraisal processes is therefore relevant for the interpretation 
of QOL outcomes. 
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Abstract
The Schedule of Individual Quality of Life – Direct Weighting (SEIQoL-DW) is an 
individualized approach in the measurement of quality of life in which patients can 
choose, value and weight ﬁve areas that they consider important for their quality of life. 
Although a number of studies have reported on the feasibility of the administration 
of the instrument, little is known about how patients choose and deﬁne these ﬁve 
areas, the so-called ‘cues’. This article describes problems in the elicitation of cues 
experienced in a qualitative, exploratory study among small-cell lung cancer patients 
(n=31) in the Netherlands. Cues originate from patient-interviewer interaction 
which is best described as an area of tension between the patient’s answers and the 
instrument instructions. As a result, the interviewer may inadvertently introduce bias 
while attempting to elicit cues, ultimately affecting patients’ SEIQoL-DW measures. 
In order to prevent possible unnoticed interviewer bias special attention should be 
paid to the interviewer behaviour. Methods to record the meaning of cues should be 
considered. More research is needed in order to investigate differences in nominating 
cues with and without the use of the prompt list.
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Introduction
Quality of Life (QoL) is increasingly being incorporated in clinical research and is 
considered a necessary end point in palliative medicine.1-3 In traditional approaches to 
the measurement of QoL, a generic content of relevant domains, criteria and weights 
is constructed.4 However, the use of predetermined tools has come under criticism. 
There are arguments that standard tools contain items that may not be relevant for 
all individuals and it is assumed that all aspects applied are of equal importance for 
all respondents.5 Individual QoL measurements provide the possibility to respondents 
to represent their individual perspective by indicating and rating the areas that are 
most important to their QoL. The Schedule for the Evaluation of Individual Quality of 
Life (SEIQoL) and its shorter Direct Weighting (DW) version is such an individualized 
approach, in which subjective needs and desires can be identiﬁed.The instrument is 
based on the deﬁnition: “quality of life is what the individual determines it to be”.6-9
The SEIQoL has been validated in healthy subjects and non-healthy populations.4;6;9-13
The relative strengths and weaknesses of the instrument have been addressed 
in the literature.14;15 Moons et al.15 have examined aspects of validity, reliability 
and responsiveness of the SEIQoL-DW and argue that the instrument measures 
determinants of QoL rather then QoL itself.
Since the introduction of the SEIQoL and the SEIQoL-DW, many studies have 
reported on the feasibility of using the instrument to measure QoL in speciﬁc patient 
populations such as patients with amyotrophic lateral sclerosis16;17, Alzheimer’s 
disease18, mental illness19, leukaemia20, cancer patients participating in phase I clinical 
trials21;22 and older medical patients.23 The SEIQoL-DW has been explored in palliative 
medicine.12 Waldron et al.13 report that patients with incurable cancer are very good 
judges of their own QoL, with very high levels of consistency and validity.
SEIQOL-DW
The SEIQoL is administered in a standardised semi-structured interview format. 
In the ﬁrst step the individual is asked to name the 5 areas of life (cue elicitation)
considered to be important for his/her overall QoL. The second step is to rate the level 
of functioning on each of the elicited areas. The third step is to weight the relative 
contribution of each area to overall QoL by means of judgement analysis. To enhance 
the applicability of this method in routine clinical situations, the quite cumbersome 
weighting technique of judgement analysis has been replaced with a simpler ‘Direct 
Weighting’ (DW) procedure. The relative contribution of each area to the overall 
QoL is weighted in SEIQoL-DW by means of a set of ﬁve coloured disks.7;10;11 In both 
the SEIQoL and the SEIQoL-DW, a global QoL score is calculated by multiplying the 
individual’s self rating on each area by the corresponding weight, and summing 
up the products. The SEIQoL-DW manual describes the procedure which has to be 
followed in the elicitation, rating and weighting: what to read as an introduction; 
what to ask and how to rephrase in order to elicit 5 cues and what to say in each 
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further step. Not all cues should be accepted. In case of the respondent volunteers 
cues which resembles ‘quality in life’ in meaning (e.g. satisfaction, life quality’) the 
interviewer has to probe for more speciﬁc cues such as ‘happiness’, or ‘attitude to 
life’. It is explicitly advised: ”Elicit areas… NOT individuals, e.g. marriage, not wife”, and 
“Do not give examples”, and to fully explore and document the meaning of each cue 
on the ‘Cue Deﬁnitions Record Form’. Furthermore, potential and most commonly 
encountered problems in the nomination of cues, the determination of cue levels and 
the weighting of cues are described. A suggested solution if a respondent cannot think 
of 5 cues is to use the prompt list with the most commonly elicited cues, i.e. family, 
relationships, health, ﬁnances, living conditions, work, social life, leisure activities and 
religion/spiritual life. This prompt list “provides for consistency across interviewers where 
such prompting is absolutely necessary”. The interviewer must read the list, excluding 
any cues already mentioned.7
Cue elicitation in our Response Shift study
We used the SEIQoL-DW in our study ‘Response Shift in Quality of Life in the palliative 
treatment of small-cell lung cancer patients’, a qualitative exploratory longitudinal 
multiple case-study involving 31 patients. It is suggested that the SEIQoL-DW might 
be a useful instrument for the measurement of response shift (i.e. a change in the 
meaning of the self evaluation of quality of life resulting from changes in internal 
standards, values, or conceptualization).24 The ability of the SEIQoL-DW to investigate 
response shift as an important mediator in the accommodation of changes in health 
status, opens up the possibility to acquire better understanding of how patients make 
the best of their condition by coping, rethinking and reframing their experiences.22;25
When, at different points in time, patients indicate different areas of their life (cues), 
this could represent a reconceptualization, and a change in their weighting of areas 
could reﬂect a change in values. In order to assess these response shifts accurately, 
cues have to be elicited and recorded in a reliable way. 
Most studies mentioned above report on the feasibility of administration, under-
standing the instrument, the time taken to administer the instrument and the 
percentage of patients who experienced difﬁculties in identifying ﬁve areas. However, 
little has been reported about the elicitation and recording of the cues. Campbell 
& Whyte21 found that the ﬁrst two or three cues were nominated spontaneously 
but thereafter elicitation became more difﬁcult with hesitation from all 15 patients 
participating in a phase I clinical trial. Only one patient managed to elicit ﬁve cues 
without prompting; all the others required to be read the prompt list. Mountain et 
al.23 reported similar ﬁndings in their study of older medical patients. Although, both 
studies reported on difﬁculties in the elicitation in more detail, they do not report on 
‘what actually happens’ in the elicitation of cues. 
In order to get insight into the process of elicitation, i.e. the nomination of reliable 
and relevant cues, exploration of ‘what actually happens’ in the interaction between 
interviewer and patient is necessary. In this article we describe problems in the 
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elicitation of cues. Findings on measuring response shift with SEIQoL-DW will be 
reported elsewhere.
Methods
Procedures and participants
All patients were recruited from ﬁve outpatient clinics for lung diseases in the 
Netherlands, between March 2001 and September 2003. Patients diagnosed with 
small-cell lung cancer (limited and extensive disease) and beginning their ﬁrst-line 
chemotherapy were reported to the researcher (MW). Of the 41 consecutive patients 
who were contacted and informed about the study, 34 agreed to participate and gave 
informed consent; 3 were not interviewed because of imminent death. Consequently, 
ﬁrst interviews (T1) were held with 31 patients (16 men and 15 women, aged 39-
82 years). Approval for this study was obtained from the ethics committees of the 
research site and the participating hospitals.
Patient interview 
Each ﬁrst interview was conducted in a format with three consecutive parts. Firstly, QoL 
was measured with the EORTC QLQ-C30 (general) and the QLQ-CL13 (lung cancer 
module).26;27 Secondly, the SEIQoL-DW was explained and administered. Finally, the 
patients were asked about changes in their perspectives with regard to their life and 
its quality. The interviews were conducted by the ﬁrst author (MW). The time taken 
to complete the SEIQoL-DW was 10–30 minutes. The interviews were audio-taped and 
fully transcribed, and all but two interviews were held in the home of the patient. 
Analysis
Findings are based on three types of data. First, the cues and notes recorded by the 
interviewer on the Cue Deﬁnitions Records Form. Secondly, the audio-tapes and 
transcriptions of the administration of the SEIQoL-DW. Thirdly, observations of 
the behaviour of the patient, recorded in ﬁeld notes made by the interviewer after 
completion of the interview. These data were analysed for each of the 31 patients 
separately, resulting in 31 case-studies. The aim in each case-analysis was to investigate 
the administration process, focusing on the elicitation of cues, the interaction, 
the role of the interviewer, the ultimate decision on cue labels, the meaning and 
categorization of the nominated cues, and any possible bias effects. Analyses of 
interviews in which patients were not able to complete the whole elicitation were 
also included to illustrate the problems that were encountered. After the individual 
cases-analyses had been completed, similarities and differences between cases were 
analysed. The analyses were performed by the interviewer (MW) and checked by two 
other members of the research team (TH and AT).
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Table 1. Areas mentioned as important by patients after diagnosis of small-cell lung cancer
Cues
(n=126)
Patients
(n=26)
Areas %  %
Issues related to family: 30  96
My husband; my wife; my children, becoming a granny, grandchildren; 
contact with my grandchildren; support from my family; to sort things 
out with my wife; ability to enjoy my family and other relations.
Issues related to health: 14  66
Fatigue; health; to be cured; feeling physically and mentally well; being 
able to do what I want to do; becoming healthier; feeling good; not to 
get too ill; being mobile; getting back to my former daily routine.
Issues related to social life: 12 58
Social contacts; social life; contacts in my living environment; friends; 
relations; support from colleagues; club life; family not directly related.
Issues related to leisure: 11 54
Leisure activities; sports; football; playing cards and ﬁshing; sewing; my 
garden; working as a volunteer at the cemetery. 
Issues related to enjoying life: 10 46
Having a holiday; to enjoy life; time all to yourself; freedom and 
happiness; going out everywhere.
Living conditions: 7 7
Living conditions; home, garden and pets; housing conditions; a quiet 
and peaceful well-organized life; norms and values in society.
Issues related to autonomy: 6 31
Being independent; my car, my freedom; being physically and mentally 
independent; doing something on my own; continuing my former 
independent life.
Issues related to work: 6 23
Own shop; moving ﬁrm; business; work; working in alternative 
medicine; my work as baby-sit.
Issues related to ﬁnance: 2  12
Keeping control of my ﬁnances; my wife’s budget after my death; not 
being restricted in budget to enjoy life.
Attitudes towards life: 2 8
Positive thinking; putting everything into perspective.
Findings
Quality of life areas
Out of 31 patients 26 (84%) completed the elicitation procedure and nominated a 
wide variety of cues (in total 126). Aspects related to family were mentioned most 
frequently: 38 times (30%) by 25 patients; cues in the area of ‘health’ were nominated 
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18 times (14%) by 18 patients; 15 cues were nominated in the area of ‘social life/other 
relations’ (12%), 14 cues in the area of ‘leisure activities’ (11%), and 12 cues in the area 
of ‘enjoying life’ (10%). Cues and percentages of other areas are presented in Table 1.
The content and variety of cues was as expected from reports in the literature. However, 
unique for our study is that we looked into how these results were produced. 
First of all we show how patients responded to the initial question “What are the ﬁve 
most important areas of your life at present…the things which make your life a relatively happy 
or sad one at the moment… the things that you feel determine the quality of your life…?”. 
Patient
Initial remarks
Out of the 31 patients, there was only one patient (low level of education) who found 
the initial question too difﬁcult and did not want to continue with the SEIQoL-DW 
interview. All other patients responded spontaneously and gave a concise description 
of an area of life which could be labelled as such (n=21) or a more elaborate one (n=9).
Some examples of their replies are the following (cue labels as registered on the Cue 
Record Form in underline print):
Well, to recover… as clear as daylight... that’s it [M, age 46]
That’s not so difﬁcult… as soon as I can, walk into town and back again [M, age 83]
Well… my family and my grandchildren, that’s really something to ﬁght for [F, age 56]
That’s really a difﬁcult question…. my quality of life… well,… to be able to get up at a 
reasonable time, to sit at the table and to read the morning newspaper… to sit in the sun… 
to watch the news… [data omitted]… if it’s possible just to continue with my everyday life…
yes, please [M, age 72] 
Five cues
Further nomination of ﬁve cues appeared to be a task that was sometimes arduous. 
Twelve patients had no difﬁculty in nominating 5 cues spontaneously. One patient 
decided that 2 cues (relations and independence) were enough for being her “concept 
of QoL”. Thirteen patients needed to be prompted with the list: 6 patients for 3 cues; 
5 patients for 2 cues, 2 patients for 1 cue and 1 patient was not able to nominate the 
ﬁfth cue even with help of the list. 
With 4 patients, who had mentioned 1 or 2 important areas in their initial remarks, 
the interviewer decided not to continue with the SEIQoL interview. Further elicitation 
was difﬁcult for various reasons. One patient who had been ﬁred from his job a few 
years previously was very emotional, and kept on talking about his work. One patient 
was overtaken by a sudden wave of tiredness. One patient was absorbed by her fears 
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that chemotherapy would harm her eyesight, which was already poor. In a very 
personal and emotional story, one patient talked about his illness, his fears about 
the future of his family, and the injustice that he should get this disease after having 
worked so hard for 45 years. Starting the elicitation process again after this sad story 
seemed inappropriate. 
Response style
The response style differed between patients. Out of 26 patients who completed the 
SEIQoL-DW, 17 nominated their cues more or less voluntarily, without much explanation. 
An example of such a concise nomination is the ‘emotional’ elicitation of the ﬁrst three 
cues from a female patient who was living alone and had two adult sons.
R: Being healthy again… and… the children (silence, crying)
I: Don’t hurry… what’s coming to the surface… worries about them?
R: Yes... (silence)
I: Do you want to tell me more about it… or… at this moment… You’d rather not?
R: No… (silence)
I: Anything else... you’re thinking about as being important?
R: Family (coughing, clearing her throat) [ID 03, F, age 64]
Nine patients were very eager to talk and presented narratives rather than cues. For 
example, the male patient (age 72) who started with describing his everyday life (see 
initial remarks) and then elaborated on his favourite operas etcetera.
R:  Quality of life…can’t say that I appreciate much company… I must say… I never liked 
visitors… I’ve got my hobbies, my classical music and DVDs […] I like to watch TV... 
I’ don’t know if you want to hear this.. but, I like to watch the “National Geographic 
Channel”, the “Discovery Channel” and “Animal Planet”, which are all very interesting 
programmes [ID 13, M, age 72]
The more elaborate the patient’s narrative, the more “work” was needed to deduce 
cues from the patient’s answer. In such situations the interviewer’s contribution to 
the formulation of a cue was crucial.
Interviewer
Premature categorization
In our ﬁrst (pilot) interview, the interviewer was focused by the instruction in the 
manual to elicit areas and started from the assumption that the patient would 
nominate a more or less abstract area. However, theory and practice differed.
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R: Areas... erm… you mean… ? If I say fatigue… or… what do you mean?
I: Well… fatigue…. Does that concern…. your… er... health?
R:  Yes… but for me… I ﬁnd it hard to describe… when I’m feeling miserable… I try to enjoy 
every day… [..]
I: Are there other things, which are important… which you need to have… ?
R: Yes, of course… everything that’s around you, your family…
I: … your social relations... ? [F, age 42]
This interview was analyzed and discussed intensively in the research team. There was 
agreement that, the interviewer, had reacted in an inappropriate way by immediately 
labeling the initial remarks fatigue and family in terms of cues from the prompt list: 
health and social relations respectively. A decision was made to avoid such premature 
categorizations and, in subsequent interviews, to accept the initial remark as cue label 
and to categorize afterwards in the ofﬁce. 
Accepting concrete aspects e.g. individuals
In subsequent interviews the patients talked in their own way about sensitive issues, 
and the interviewer responded and adapted the conversation accordingly, taking into 
account the seriousness of the situation. It was difﬁcult for the interviewer to follow 
the instruction to ”Elicit areas… NOT individuals, e.g. marriage, not wife” because of a 
tendency to name concrete aspects, e.g. individuals. Of twenty-six patients 20 were 
married. All but one of them mentioned individuals, i.e. my wife or my husband as 
being important. None of them mentioned marriage as a cue. In some cases patients 
combined their partner with children and/or grandchildren as family. Family was 
mentioned regularly in a context expressing meaning, for example “the ability to 
function well in my family as wife and mother”, “keep on thinking positively for my family”,
“receiving much loving support from my family” and “to sort things out with my wife”.
Furthermore, patients distuinguished between close and not directly related family. 
Probing, deducing and reorganizing cues 
The meaning of each cue must be documented on the Cue Deﬁnitions Record Form. 
However, meaning was not expressed in words alone. It could be read between the 
lines, in the intonation, in the silence, the choice of speciﬁc words, etc. Patients were 
telling complete and different stories in nominating a cue. In general, the interviewer 
endeavored to establish the meaning of what actually was said, but the method 
differed depending on the style of patient’s response. In patients who named their 
cues in short descriptions the interviewer probed for further explanation. Because all 
the interviews were audio-taped, it was not necessary to write down the meaning of 
cue labels in detail, which made the atmosphere more relaxed.
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R: To live a comfortable life… and… with enough money, that’s important…
I: Two aspects at the same time… to live a comfortable life… enough money… ?
R:  Yes, it has to be like that, because if you don’t have enough money… you can’t live a 
comfortable life… everything included… [M, age 66]
In patients with a more elaborate response style the interviewer needed to unravel what 
mattered to the patients, i.e. to deduce cues from the answer. On occasion, aspects were 
reorganized such as combining two aspects that were mentioned into one cue.
R:  Yes… ﬁnancially, I’m trying to look into the future, when I won’t be here anymore. I’m 
busy thinking about her… will she able manage the ﬁnances… I need to know (silence).
I:  Yes, well we talked about the various aspects, health… social relations… classical 
music…information on TV… being able to continue with your everyday life… we have 
ﬁve already… and at the same time you’re saying… ﬁnances are important… ?
  If we put together classical music and information on TV… then there is room for ﬁnances 
as well… would that be a good idea… ?
R: Yes… [M, age 72]
Actually, together with the respondent the interviewer identiﬁed cues from the 
answers that were given, summarized and asked if any mistakes had been made, and 
documented cue labels in words chosen by the patient.
Introducing prompt list e.g. health
Thirteen patients were unable to choose 5 cues, therefore the interviewer had to make 
suggestions from the prompt list. While reading the list, patients weighted the pros and 
cons and aspects were recognized as important enough to mention in order to bring the 
total to 5. Provided cues turned out to be very important and/or self-evident, e.g. health.
Yes… health… on the top of the list… otherwise you can’t enjoy other things [F, age 69]
Out of 18 patients who mentioned health as cue, 5 patients nominated health with 
help of the prompt list. Although they did not mention health voluntarily, three 
of them weighted health as ﬁrst and most important. Despite the fact that all the 
patients were in the process of starting chemotherapy and knew about their poor 
prognosis, 8 out of 26 did not mention any cues related to health. Of these 8 patients 
6 nominated their cues without use of the list and the other 2 were not prompted by 
the list to mention health. Although these 8 patients did not mention health, aspects 
related to health were self-evident, for example, as a goal to accomplish and/or in 
descriptions of their cues: 
If I’ll be cured.. we’ll go to Curacao. I’ll be brave enough to ﬂy… [F, age 50]
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The most important thing is my relationship with my wife… that we have sorted out everything, 
… when you are diagnosed with cancer… you might think you’ll die soon… [M, age 64]
Discussion
Asking people to introspect their life in the context of being recently diagnosed 
with small-cell lung cancer seems to border closely on the invasive. However, many 
patients were eager to talk about sensitive issues, and to tell the interviewer what 
was important for their QoL in the format of ﬁve cues. The percentage of patients 
who were able to complete the SEIQoL interview is in accordance with ﬁndings from 
previous studies in other patient populations.11;17-21 Reasons for non-completion 
are in line with ﬁndings from Mountain et al.23, i.e. confusion, distress, fatigue and 
blindness.
The content and variety of cues was as expected from reports in the literature, 
with family as the most frequently mentioned aspect (96%). Twenty-ﬁve patients 
mentioned 38 cues in the area of family, which means that some patients mentioned 
more than one cue in the same area. Our ﬁndings, i.e. that patients named individual 
members and distinguished between partner, children, grandchildren and other 
family members were identical to the ﬁndings of Campbell & Whyte21, and explain 
the nomination of more than one cue in the area of family.
The prompt list was needed for half of the patients, which is in contrast to other 
studies such as Frick et al.28 and Campbell & Whyte.21 Frick et al. reported no need at all 
(0%) in his research of 79 patients undergoing autologous peripheral blood stem cell 
transplantation. Campbell & Whyte reported that 14 out of 15 oncology patients (93%) 
needed the prompt list. The very disparate results between these two studies, as well as 
compared to our own, suggest that the elicitation of cues is interviewer dependent.
In our study, 2 patients completed the administration with less than ﬁve cues. In 
fact, the interviewer (MW) made a choice to accept less than 5 cues, rather than to 
elicit cues artiﬁcially, and the risk of choosing a “socially desirable” concept of QoL. 
Nominating less than 5 areas seems to be entirely consistent with what could be 
expected from people whose “horizons” are shrinking. The inability to nominate 5 
cues, and the implicit assumption that QoL is reducible in this way, has also been 
reported by Macduff.14 Campbell & Whyte argue that it may be unproductive to 
encourage the patient to choose a total of 5 cues.
Bowling29 reports differences between voluntary cues and prompted cues. When 
respondents in her study selected their own cues from a show card, there were some 
discrepancies with their (ofﬁce-coded) verbatim replies (which were recorded by the 
interviewer before the respondents saw the show card). This discrepancy illustrates a 
possible bias when prompting cues. In our study health was nominated as a cue in 5 
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patients with help from the prompt list. Interestingly, their weighting of health was 
high. It could be argued that the list helps people to nominate important cues, which 
are “forgotten” because they are self-evident. This ﬁnding raises the question of the 
6 patients who nominated 5 cues without help of the list and did not mention health
as cue. It can be assumed that some of these patients would reconsider their cues and 
nominate health after checking with the prompt list. 
Although Bowling’s results and the present ﬁndings suggest possible inﬂuences of bias 
when using the prompt list, it could be argued in favor of providing cues. The ability 
of patients to express themselves in an abstract concept of QoL differs, and important 
information may not be disclosed, valued and weighted if it is not explicitly asked for. 
Therefore, Wettergren et al.30 used an extended Swedish version of the SEIQoL-DW 
with a disease-speciﬁc module to identify speciﬁc issues. More research is needed in 
order to investigate differences in nominating cues with and without the use of the 
prompt list.
Our ﬁndings show that cues were not just the result of a process of elicitation and 
subsequent recording. Cues originate from the patient-interviewer interaction, which is 
best described as an area of tension between the patient’s answers and the instrument’s 
instructions, in which the interviewer is trying to balance freedom and control. Eliciting 
cues implies making decisions about: 1) what to accept as a cue, 2) when to probe for 
further clariﬁcation, 3) which cue to deduce from the answer, 4) when and how to 
reorganize cues, 5) whether and when to use the promptlist, 6) whether and when to 
accept less than ﬁve cues, 7) when to discontinue further elicitation, 8) how to label 
and record the meaning of cues and 9) when and how to categorize. It is conceivable, 
however, that SEIQoL-DW data are vulnerable to unnoticed bias, because of intra- and 
interinconsistencies in the behavior of the interviewer(s).
Meaning
The quality of SEIQoL-DW is not only to measure QOL, but also to grasp “what 
really matters to patients”. The methodology entails discussing the answers given 
by respondents in order to make them more concrete, or if needed, less abstract. 
The aim is to have a good understanding of the meaning of each cue, but without 
accurate recording this meaning disappears as soon as categorization takes place. It 
could be argued that in research with a global index score as main outcome the 
recording of this meaning is of less importance. However, in longitudinal and 
response shift research, as well as in the clinical setting, where the instrument is used 
therapeutically, meaning is crucial to reliable categorization and correct interpretation 
of cues and scores. After all, if family can connote for example in the ﬁrst interview 
‘staying positive for my family’ and in the second ‘I’m happy with the support of my 
family’, then these cues refer to the same area of family, but the outcome data has 
to be interpreted differently. In other words, cues categorized in the same area may 
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have different meanings and cues categorized in different areas may have a similar 
meaning. Therefore, the question how to record arises. Although it is possible to 
express meaning in a short description of the label on the Cue Deﬁnitions Record 
Form, it could be questioned whether this can be done accurately and consistently 
over time and across interviewers. 
Conclusion
Since the introduction of the SEIQoL-DW, recommended by Hickey et al.11 as relatively 
simple to administer and requiring minimal training in the form of the manual, 
many studies have reported on the acceptability of the instrument. Our study shows 
that cues originate from patient-interviewer interaction which is best described as an 
area of tension between the patient’s answers and the instrument instructions. The 
instructions on how to elicit these cues are not described in sufﬁcient detail in the 
manual. In order to prevent possible unnoticed interviewer bias in the elicitation of 
valid and reliable cues special attention should be paid to the interviewer behavior. 
If correct interpretation of cues and scores is crucial, methods to record the meaning 
should be considered. More research is needed in order to investigate possible 
differences in nominating cues with and without the use of the prompt list.
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Change in what matters to palliative patients: 
Eliciting information about adaptation with SEIQoL-DW 5
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Abstract
This study was carried out to investigate the usefulness of the SEIQoL-DW to elicit 
information about response shifts in palliative patients. The instrument measures 
individual quality of life and allows respondents to choose, rate and weight 
important areas of life (cues). We explored patients’ reconceptualizations (i.e. change 
in cues) and their value change (i.e. change of cues weights). Results of twenty-one 
patients showed what mattered to these patients and how they had adjusted to 
deteriorating health. There is a risk that repeated measurements do not to provide 
all the information which is in potential present and relevant to explore response 
shifts. But clear instructions to interviewers, such as careful listening, probing self-
evident cues such as health and family, and accurate recording of cues on the forms 
may overcome this risk. Future research is recommended to explore the possibilities 
of regular assessments to facilitate better adjustment of patients.
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Introduction
Quality of life (QoL) is considered an important goal in clinical practice and particularly 
relevant to palliative medicine.1-3 However, the expected deterioration in QoL often 
does not occur, even in cases of serious illness.4-6 There is ample evidence that the 
occurrence of response shift complicates “objective” evaluation of treatment and 
quality of care.7-10 Alternatively, response shift might be seen as a desirable outcome 
of adaptation. From both perspectives it is necessary to ﬁnd out how response shift 
could be investigated.11
Schwartz and Sprangers deﬁned response shift as a change in the meaning of one’s 
self-evaluation of a target construct as a result of a) a change in internal standards of 
measurement, b) a change in values or c) a redeﬁnition of the target construct (i.e. 
reconceptualization). They evaluated different approaches to the measurement of 
response shift.11 Two categories of approaches appeared to be immediately applicable, 
because they allow the use of existing QoL instruments: 1) design approaches, e.g 
“then-test”12, and 2) repeated use of individualised methods.13
The Schedule for the Evaluation of Individual Quality of Life – Direct Weighting 
(SEIQoL-DW)14 is such an individualized approach which measures the unique 
individual perspective on QoL. Patients can choose, rate and weight ﬁve areas 
(cues) that they consider important. O’Boyle et al. 13 deﬁned change in cues between 
ﬁrst and second interview as reconceptualization, and change in the weighting 
of identical cues as value change. Two studies used the instrument explicitly 
to identify reconceptualization and value change. In the study of Echteld et al.
SEIQoL-DW was assessed in patients admitted to units for terminal care at one, 
three, and ﬁve weeks after admission, to determine the extent to which response 
shift inﬂuenced QoL.15 Sharpe et al. investigated the relationship between response 
shift and adjustment in patients with metastatic cancer patients at baseline, and 
three and six months later.16 However, both studies differ considerably in the level 
of abstraction of nominated cues. Scharpe et al., for example, reported family 
without further deﬁnition, whereas Echteld et al. reported family but deﬁned as 
maintaining good contacts with family. In a previous study, we investigated the 
way in which patients choose and deﬁne their cues17, and we found that complete 
stories are told in the elicitation procedure and that the interviewer makes 
decisions what to write down on the form as label and deﬁnition. Therefore, we 
questioned whether the measurement of response shift could be prone to error 
when the meaning of cues (i.e. patients’ story told in the elicitation) is not taken 
into account.
It has been suggested that the SEIQoL-DW is useful for eliciting information about 
adaptation (i.e. response shift). It has not previously been investigated whether 
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the data of repeated measurements are unambiguous and provide all the relevant 
information that is needed to determine whether response shift has occurred. We 
did so in a population of small-cell lung cancer (SCLC) patients during palliative 
chemotherapy.
Methods
Participants and procedure
Newly-diagnosed SCLC patients, who were evaluated for ﬁrst-line chemotherapy, were 
recruited from ﬁve outpatient clinics for chest diseases in the Netherlands. Participating 
patients gave written consent and were interviewed during the treatment trajectory. 
The project was approved by the Medical Ethics Committee of the VU University 
Medical Centre. The ﬁrst interview (T1) was held at the start of chemotherapy, the 
second (T2) 4 weeks later, the third (T3) after completion of the chemotherapy course, 
and the fourth (T4) six weeks later. The SEIQoL-DW was assessed, as described in the 
manual. Assessments were audio-taped and fully transcribed verbatim.
SEIQoL-DW
The SEIQoL-DW is administered in a standardized interview format.14;18;19 First, ﬁve 
areas of life (cues) that are considered central to the individual’s QoL are elicited by 
asking: “What are the ﬁve most important areas of your life at present… the things which 
makes your life a relatively happy or sad one at the moment… the things that you feel 
determine the quality of your life…?”. If cues are not nominated spontaneously, a list of 
nine frequently mentioned cues can be proposed15. Secondly, the patients’ perceived 
level of functioning within each cue is recorded, using vertical visual analogue scales 
ranging from “As bad as could possibly be” (value 0) to “As good as could possibly be” 
(value 100). Thirdly, the patients are invited to rate their current overall QoL on a 
horizontal VAS scale with the same anchors as the vertical scales (value 100). Finally, 
the relative importance (i.e. weight) of each cue is recorded using a disk with ﬁve 
coloured sections, representing each elicited cue. Respondents are asked to change 
the sizes of the coloured sections by rotating labels attached to the sections until 
they correspond with the perceived weight of the cues. A total weight score of 100 is 
distributed over the ﬁve cues. An overall score (SEIQoL-index, range 0-100) is then 
calculated: the sum of cue levels multiplied by cue weights, and divided by 100.
Analysis of response shift 
The ﬁndings reported in this article are based on two types of data: 1) the Cue 
Deﬁnitions Records Form (form) with written information (i.e. cues, deﬁnition, 
weights, Index-score and notes about procedure), and 2) transcripts of the audio-tapes, 
which were analysed in Kwalitan 5.0, a software package for ordering qualitative data. 
Reconceptualization and value change was investigated in each patient (case) per 
transition, i.e. determining changes in cues and their weighting between T1 and T2, 
between T2 and T3, and between T3 and T4. Reconceptualization was determined by 
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comparing cue labels and their deﬁnition (patient’s own words) as written on the forms. 
These ﬁndings were compared with information from the transcripts to determine 
whether the identiﬁcation of cue change was correct. Analyses were performed by 
two members of the team (MW, TH). They categorized per transition each instance of 
change in cues and each instance of no change in cues. They compared and critically 
discussed their ﬁndings in meetings and consensus was reached on the following 
categories:
1. Change in cues ͹ supported by transcripts ͹ reconceptualization 
2. Change in cues ͹ not supported by transcripts ͹ false positive reconceptualization 
3. No change in cues ͹ supported by transcripts͹ no reconceptualization
4.  No change in cues ͹ transcripts indicate reconceptualization ͹ false negative 
reconceptualization.
If no reconceptualization was found, a change in the weighting of identical cues was 
determined as value change if there was a minimum difference in weight of 10 points.
Results
Study sample
During the course of the study, 41 patients were reported to the interviewer and 
invited to participate. However, 4 patients were unwilling to participate and 6 were 
not interviewed because of imminent death. Of the 31 patients who were interviewed, 
6 patients were excluded from analysis because they were only interviewed once 
(they died within a month after T1) and 4 due to incomplete datasets (e.g. confusion, 
distress, fatigue), resulting in a study population of 21. One patient was only 
interviewed twice at T1 and T3 and died before T4. Three patients were interviewed 
three times and died before T4, resulting in a total of 58 transitions in 79 interviews 
to explore for response shift. The mean age of the 21 participants was 58 years (range 
39 – 72), 12 (57%) were female, 18 (86%) were married and 16 (76%) had children.
SEIQoL-DW during the treatment trajectory
The frequency of elicited cues (n=372) and the mean SEIQoL Index and VAS are presented 
in Table 1. Cues related to family (e.g., partner, children, grandchildren) were nominated 
most frequently. Health was the second most frequently mentioned cue (deﬁnition: e.g. 
hoping chemotherapy would not to be too tiring, being cured, successful chemotherapy, 
feeling well under the circumstances, hoping that the tumour would not reoccur). Other 
cues concerned hobby/leisure (deﬁnition: e.g. ﬁshing, gardening, making puppets), social 
life/other relations (deﬁnition: e.g. visiting friends, distant family), enjoying life/holiday,
work, living conditions, autonomy/independence, attitudes towards life, and ﬁnance.
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Table 1 SEIQoL index, VAS scores and frequency of important life areas (cues) elicited at T1 (start 
ﬁrst-line chemotherapy), T2 (four weeks later), T3 (end chemotherapy) and T4 (six weeks later) 
in small cell lung cancer patients.
Means (range 1-100) 
Quality of Life T1 (n=21) T2 (n=21) T3 (n=20)a T4 (n=17)b
SEIQoL-Index 70 83 77 82
SEIQoL VAS 70 75 81 78
Frequency (%)
Cue categories T1 T2 T3 T4
Family 34 34 33 32
Health 16 17 16 23
Hobby/leisure 14 10 12 10
Enjoying life/holiday 7 8 11 13
Social life/other relations 7 10 11 9
Living conditions 6 6 3 2
Work 5 5 4 6
Autonomy/independence 5 5 5 1
Attitudes towards life 3 3 3 3
Finance 3 2 2 1
Note: a and b patients died before (n=1) and after (n=3) the end of ﬁrst-line chemotherapy 
In 18 out of the 21 patients change in the nominated cues was observed, and mostly 
concerned a change of 1 to 3 cues. Some cues were important at one speciﬁc moment 
in time only. For example, ﬁnances nominated at T1 was not mentioned again at T2 
because ”I’m no longer worrying about my husband’s ﬁnances after my death”. There were 
two exceptions: 1) one patient changed all 5 cues at each interview; her cues were 
very concrete wishes or goals, which differed at each assessment (e.g. wisdom to accept 
the situation, strengthening the relationship with my son, searching for new goals in life),
and 2) one patient nominated only two cues in every interview and did not change 
these cues and their weights (i.e. relations (level 100, weight 50) and my independence
(level 100, weight 50).
In 16 out of the 79 interviews the prompt list was used. At T1, 10 patients nominated 
2-3 cues with help of the list. At T2, 5 of them needed to be prompted again, but at 
T3, only one of these 5 still needed the list. At T4 the list was not needed anymore, 
but two patients who had been prompted before, asked the interviewer to write down 
their previously nominated cues again because “nothing has changed”. The time 
taken to complete the SEIQoL-DW ranged between 10 and 30 minutes.
A case study
The data as shown in Figure 1a and 1b are illustrative of the information obtained from 
repeated measurements with SEIQoL-DW. Patient John (age 57) was not feeling well 
and suffered, among other things, for dyspnoea at the ﬁrst interview (Figure 1a).
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Figure 1a. Cues, levels of functioning and cue weights for a 57-year-old male patient with 
extended small-cell lung cancer, obtained 10 days after diagnosis at the start of 1stline 
chemotherapy. Family and health were nominated spontaneously; autonomy, leisure and life 
circumstances were prompted with the list of most frequently mentioned areas.
Spontaneously, he nominated the cues autonomy (deﬁnition:I don’t want to become 
dependent on others) and family (deﬁnition: my wife and children, I’m not important 
but they are).Three cues were prompted with the list, i.e. life circumstances, health,
leisure (deﬁnition: ﬁshing with friends). The level of autonomy further illustrates his 
worries about dependency. His second interview was conducted after his last treatment 
cycle. He was feeling very well and eager to talk (Figure 1b). Without help of the 
list, he nominated family (deﬁnition: my wife and children, I’m happy with their 
support), health (deﬁnition: feeling well), and three new cues friendship, social contacts 
and work contacts. The low level of work contacts illustrates his disappointment that 
his colleagues had not contacted him. Weights show family as the most, health as the 
second and social contacts as the least important. Five weeks later he died. 
John’s SEIQoL -DW data provide information about how he adapted during his 
treatment trajectory. However, further inspection of the transcripts showed more 
information, and valuable in understanding how he had adapted. He had changed his 
deﬁnition of family. In his ﬁrst interview he had given a further deﬁnition of family, 
which was not written on the form, while he was rating the level of functioning: “I’m 
worrying about whether everything has been arranged properly for my wife after my death, I 
have to arrange what’s necessary”. This deﬁnition differed from the one at the second 
interview and written on the form “my wife and children, I’m happy with their support”. 
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Figure 1b. Cues, levels of functioning and cue weights for a 57-year-old male patient with 
extended small-cell lung cancer, obtained one week after the last treatment cycle of 1stline 
chemotherapy and 5 weeks before death. Cues were nominated spontaneously.
Transcripts showed that the experience of feeling supported was new and special 
for him, and that he trusted his family with the necessary arrangements. Therefore, 
we concluded that a reconceptualization had occurred: the cue family had shifted 
from “caring for his wife and children” to “feeling supported by his family”. After 
further reading of the transcripts, the same phenomenon was seen with the cue 
health, which had shifted from “getting cured” (transcript: “that’s what we ﬁght for”)
to “feeling well”. Both shifts in the meaning of cues were not detected by comparing 
the forms. Therefore, we categorized these instances of response shift as false negative 
reconceptualization because the SEIQoL had not detected these reconceptualizations. 
Furthermore, the transcripts showed a value change: “I’ve changed my mind. I’ve said…
health was not important for me but, now I’m feeling well I’ve experienced how health strongly 
affects my life and, although not the most important thing, it is certainly the most decisive”.
Because different cues were nominated and the deﬁnition of health had shifted, we 
concluded that nothing could be said about the magnitude of this value change.
Reconceptualization
We analyzed 58 transitions in the way we did John’s data (see Figure 2). Recon-
ceptualization was observed in 25 (43%) transitions and no reconceptualization in 16 
transitions (28%). In 11 transitions (19%), no change in cues was seen but transcripts 
indicated that a reconceptualization had occurred (false negative reconceptualization). 
These reconceptualizations concerned the cues health (7 times), family (2 times), leisure
(1 time) and work (1 time). In 6 transitions (10%) a conclusion about reconceptualization 
had to be withdrawn (false positive reconceptualization, i.e. change in cues not supported 
Westerman_v3.indd   78 18-07-2007   13:00:54
C
h
ap
te
r 
5
79
by transcripts) because differences in cues were a result of different wording, recording 
and/or response style (examples of false positive reconceptualization are not reported, 
but are available from the ﬁrst author). 
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Figure 2. Measurement of reconceptualization with SEIQoL-DW in small-cell lung cancer 
patients during 1st line chemotherapy. Percentage of patients showing 1) reconceptualization, 2) 
reconceptualization not measured (false negative), 3) incorrectly measured reconceptualization 
(false positive) and 4) no reconceptualization.
Value change 
In 12 patients (57%) a value change of more than 10 points was observed in at least 
one transition during treatment. Six patients weighted their health as more important 
at the end of the treatment with a mean change of 28 (range 10-64), and 3 patients 
weighted it as less important, with a mean change of 18 (range 12-27). Family was 
weighted as more important by two patients (change from 22 to 75, and from 20 to 
33). One patient’s weighting of work ﬂuctuated during the treatment from 10 at the 
start of her chemotherapy (T1) to 3 four weeks later (T2). After the treatment (T3 and 
T4) she had plans to start with her work again and gave the area the weight of 16.
Discussion
Individual QoL appeared to improve remarkably within a 4-weeks period from 70 to 
83 at T2 and was higher than the SEIQoL-DW scores reported by Waldron et al.20 in 
advanced cancer patients and even in healthy elderly patients.21 After a slight decrease 
at T3, levels of T2 were reached again six weeks after the end of chemotherapy. Results 
of other studies in SCLC patients conﬁrm this pattern.23;24
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Repeated measurements with the SEIQoL were generating data which showed 
immediately why “expected deterioration in QoL doesn’t occur”. 4 Respondents 
changed their focus, and emphasized more positive aspects, contributing to Qol 
in stead of focusing on problems and concerns.24 The experienced support of the 
family and the knowledge that necessary issues such as ﬁnances had been arranged 
contributed positively to their QoL. These data showed how patients reconceptualized 
by nominating other cues that were important to them. The example of patient John 
showed that, solely by asking at two different points in time “What are the ﬁve most 
important areas of your life at present… the things which makes your life a relatively happy or sad 
one at the moment”, it is possible to obtain information about a patient’s adaptation.
Although not all reconceptualization was detected by comparing the two forms, the 
instrument had the potential to elicit important changes in priorities (i.e. the nomination 
of other cues), as well as changes in perspective (i.e. change within a cue). Shifts in the 
perception of health, in particualar, explained the high levels of functioning in this 
area and their contribution to good overall QoL. The audio-tapes of the interviews 
made it possible to assess these kind of reconceptualizations. 
In 6 cases the nomination of other cues was not a real response shift (i.e. false 
positive reconceptualization). This result conﬁrms Westerman’s et al. suggestions 
about dependency of the instrument on differences in the elicitation and recording 
of cues.17 Although standardization of cue elicitation (e.g. standard use of list) could 
reduce this problem, it may increase the number of unmeasured (i.e. false negative) 
reconceptualizations, because it might prevent patients from talking freely about 
issues that are important to them15;25 and valuable information about adaptation 
could be lost. 
Figure 2 shows a greater amount of false negative reconceptualization at the T3-T4 
transition, compared to T1-T2 and T2-T3. A possible explanation for this might be 
that at T4 all cues were spontaneously nominated, and because the patients were 
more experienced the cues were nominated (and recorded on the form) more or less 
as a matter of routine. 
Because SEIQoL generated relative cues that are constrained to unity11, the measure-
ment of value change has its shortcomings. Only when no change at all occurs in 
the nomination of cues, the value changes are clear. The nomination of just one 
new cue might also change the weight of the other 4 cues. In this study we chose 
to investigate the prevalence and quality of value change and not to measure the 
quantity of change. However, reconceptualization and value change are actually two 
interwoven concepts in SEIQoL-DW measurements. Although the nomination of a 
new cue could be considered as reconceptualiation, it could also be considered as a 
value change or reprioritization (e.g. nomination of holiday instead of ﬁnances suggests 
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a value change of the cue ﬁnances to zero). The listing of cues in order of priority might 
overcome the earlier mentioned problems in measuring value change (see e.g. Sharpe et 
al.16). Furthermore, ranking opens up the possibility for the interviewer to ask at T2 for a 
ranking including the cues that were mentioned at T1, but not mentioned at T2.
Conclusions and recommendations
The SEIQoL -DW was found to be useful in exploring response shifts. But, there is 
a risk that repeated measurements do not to provide all the relevant information 
which is necessary to determine whether a response shift has occurred. Audio-taping 
was beneﬁcial to us in detecting these pitfalls. However, it is not necessary to audio-
tape each assessment. It is recommended to listen carefully, to probe in particular 
the cues which are self-evident (health and family), to record the meaning of cues 
accurately, and to give clear instructions when other interviewers are involved in the 
assessments.
In the assessment of SEIQoL-DW valuable information was elicited about what 
really mattered to patients in the face of adversity, and whether response shifts 
had occurred. Whereas several studies show that response shifts are associated with 
favourable QoL, the question that arises is whether response shifts might be induced 
in patients who have trouble in adjusting to changing health. Especially when a cure 
is unlikely, clinicians are just as concerned with changes in how a patient feels as with 
the more strictly physical aspects of the patient’s medical condition. An important 
objective of therapy may be to facilitate changes in the way particular states are 
experienced. Wilson26 showed that, from a clinical perspective, response shift is not a 
new phenomenon, and that facilitating coping processes in ways that improve QoL 
is part of clinical care. Therefore, our study justiﬁes future research to investigate the 
possibilities of regular SEIQoL assessments in clinical practice to ﬁnd out: 1) whether 
and how patients are able to adjust to changing health, and 2) whether the obtained 
results can assist clinicians in helping patients to understand, to cope and to rethink 
and reframe their experiences so that they can make the best of their condition.26
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The struggle behind “I’m all right”: 
Adaptation in cancer patients 6
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Abstract
Objective
To investigate the factors that result in positive self-reports, despite deteriorating health 
in small-cell lung cancer patients.
Design
Prospective longitudinal multiple case study with home interviews.
Setting
Five out-patient clinics for chest diseases in the Netherlands.
Participants
31 newly-diagnosed small-cell lung cancer patients who were evaluated for ﬁrst line 
chemotherapy.
Results
Patients were ﬁrstly and predominantly struggling to manage the side-effects of 
chemotherapy, to think positively and to fulﬁl their duties as a family member. 
Their struggle to maintain a sense of control over their life went hand in hand with 
giving up goals and expectations which were no longer important or tenable. Despite 
deteriorating health, most patients managed to keep going and still enjoy life by 
living it day by day and treasuring the good moments.
Conclusion
Acknowledgement of the struggle behind positive self-reports may assist physicians 
in their approach to patients with a terminal illness, and to discuss hope as well as 
end-of- life issues.
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Introduction
Many patients with incurable cancer are willing to undergo risky and toxic treatments 
which can have an impact on their quality of life (QoL).1-4 Since QoL is considered 
to be a necessary end-point in palliative medicine, it seems plausible to presume that 
doctors are happy when patients report that they are “all right”. However, there is an 
awareness that the patients’own evaluations may differ considerably from those made 
by clinicians and signiﬁcant others.5;6 Actually, QoL research often yields counter-
intuitive ﬁndings. Patients with a life-threatening disease have been found to report 
a stable QoL, and the QoL of patients with a severe chronic illness was found to be 
no worse or no better than that of less severely ill patients or healthy people.7-10 It is 
suggested that patients make the best of their condition by coping, rethinking and 
reframing their experiences, and that this adaptive self-regulation may explain these 
discrepancies.11;12
We investigated aspects which contribute to the fact that patients are able to say “I’m 
doing all right” from the perspective of the terminally ill patient, despite deteriorating 
health. This topic is important because positive self-reports affect the decision-making 
concerning treatment and the discussion of end-of life issues. 
Methods
Our study was based on observations made by AT (second author), who had carrried 
out an ethnograﬁc study among small-cell lung cancer patients focusing on the 
role of collusion in the doctor-patient relationship contributing to “false optimism 
about recovery”.13 During observations and interviews in the university hospital it 
became apparent that these patients who were treated with chemotherapy did not 
report the deterioration in QoL which, objectively seen, would be expected, and that 
they reported less distress than they actually experienced. We designed a qualitative 
exploratory longitudinal multiple case study among others to investigate factors that 
contribute to positive self-reports of well-being and QoL. We draw comfort from the 
fact that AT had discovered in these patients a common illness trajectory consisting 
of ﬁve stages: i.e. 1) existential crisis after diagnosis, 2) focus on therapy during 
the initial treatment period, 3) relative peace of mind after treatment, 4) another 
existential crisis when a recurrence of the cancer was diagnosed, and 5) the ﬁnal crisis 
when the patients knew that no further treatment with chemotherapy was available 
or feasible. 
Data were collected through home-interviews and at equivalent points during 
ﬁrst-line chemotherapy: at the start, 4 weeks later, after the last cycle and 6 weeks 
after completing the (ﬁrst) course. Furthermore, at the start and the end of further 
chemotherapeutic treatment. Each interview consisted of two consecutive parts. 
Firstly, QoL was assessed by means of two measurements (the results will be reported 
elsewhere) Secondly, the interviewer (MW, ﬁrst author) encouraged the patients to 
talk freely about their experiences with the treatment, and about “what matters 
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most” with regard to their life and its quality. After each interview MW made ﬁeld 
notes about her observations and the informal conversations after the interview. The 
interviews were audio-taped and transcribed verbatim. 
After approval by the Medical Ethics Committee of the research site and the participating 
hospitals, recruitment commenced in ﬁve outpatient clinics for chest diseases in the 
Netherlands. Forty-one consecutive patients, diagnosed with small-cell lung cancer 
(limited and extensive disease) and evaluated for ﬁrst-line chemotherapy, were approached 
between March 2001 and September 2003. Seven felt unable to participate, and three 
died after giving written consent. The age of the patients who actually participated (n=31) 
ranged from 39 to 82 years, and 15 (48%) were female. The majority were living with a 
spouse (25, 81%) and had children (26, 84%). However, 8 patients died during the ﬁrst 
course of treatment and 2 immediately afterwards. Six weeks after the course (T4) only 21 
patients were still alive and could be interviewed. Six of these patients were interviewed 
again (in January 2004 data-collection had to be closed), and of these 6, 2 died during the 
second course and 3 died shortly afterwards. One female patient (age 42) was interviewed 
again at the start and the end of a third course. 
The ﬁndings are based on the analysis of three types of data. Firstly, transcripts of 112 
formal interviews. Secondly, ﬁeld notes with a detailed description of the observations 
and informal conversations with patients and spouses. Thirdly, the log book in which 
telephone calls were recorded when appointments for interviews were made. The data 
were analysed per patient, resulting in 31 case studies.14 The aim of each case-analysis 
was to investigate adjustment in patients with incurable cancer and the factors that 
result in positive self-reports, despite deteriorating health. Kwalitan 5.0 was used as 
software package for the qualitative analysis of the transcripts (www.kwalon.net).
After individual case-analyses were completed, similarities and differences between 
cases were analysed. The analyses were performed by MW and AT, and there were 
critical discussions about the results with the other members of the research team.
Results
Management of expectations 
The patients were informed about the risks and side-effects of chemotherapy and 
the fact that the treatment would probably exhaust them or make them feel more 
ill than they already were. However, the expectations differed from their experiences 
(see Box 1). After the ﬁrst treatment cycle, most patients were relieved to have 
suffered less than they had expected. Some patients with extensive cancer were even 
feeling psychically better than before because of an alleviation of their symptoms 
(e.g. dyspnoea and coughing). This ﬁrst experience with the chemotherapy, seemed 
to lift the patients out of their existential crisis and to give them back a sense of 
control. This sense of control was enhanced by the 3-weekly routine of check-ups and 
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treatment, with a predictable number of bad days, days of recovery, and days to pick 
up their normal life again. But, like an uphill struggle, the impact of every new cycle 
was experienced as more and more severe, and most patients had some very difﬁcult 
days with considerable suffering caused by the treatment. Six weeks after the course, 
fatigue and a decline in functioning was obvious, but for most patients it was a relief 
to have endured the treatment and to be feeling much better than immediately after 
the course: “You really feel that you´re quite somebody again, compared with just after the 
chemo. Of course I´m not as good as before, but sometimes you think that it´s all a mistake, 
that you haven´t got cancer because you feel so good. But, yes, you are terminally ill and 
every day can be your last” [female, age 69].
Expectations and experiences
Not as ill as expected
The doctor said ´you must have chemotherapy, as soon as possible´. So then I started, but I 
must say that it hasn´t really made me feel ill yet. 
[male, age 66, second interview]
Well, they say now that I´m in between the tenth and the ﬁfteenth day, and then I should 
really be very tired, but I still go shopping in the mornings. 
[female, age 56, second interview]
I´ve really been very lucky that the chemo has hardly bothered me at all. 
[male, age 65, third interview]
Feeling better all the time
People think it´s strange that you say I don´t feel any different. You hear all these stories 
about the chemo that it makes you feel really ill. Of course it´s not nice, but it wasn´t too 
bad and actually I feel better after every course. 
[male, age 67, third interview]
Then I heard that I had cancer and, you see, it´s incurable … Yes, then you start thinking 
about what will happen … it will only get worse … but with me it´s really only got better. 
So, actually, it was exactly the opposite with me. 
[male, age 39, third interview]
Becoming very ill
The last chemo made me very ill. I was so ill that I thought I wasn´t going to make it. 
I did nothing but vomit and vomit, and on top of that I also got the ´ﬂu. Never again, 
I thought!
[female, age 44, third interview]
Well, then it begins in the evening – sick, oh terribly. I can´t even tell you how awful. 
I sometimes wished I was dead. So ill. You can´t tell any man that … sweating and soaking 
wet right down to my toes. 
[male, age 73, third interview]
Box 1
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Managing prognosis
Adopting a positive attitude and presenting one selves as “doing all right” seemed 
to function as an anchor for the patients in the struggle of shifting back and forth 
between awareness, acceptance and denial of their prognosis. Fifteen patients (out of 
the 21 who were still alive after the ﬁrst course) said that they had regained control 
over their life by forcing themselves to think positively (see Box 2). They tried to put 
the issue of prognosis out of their mind by suppressing thoughts that arose and by 
focusing on the positive effects of the treatment. Feeling better than they had expected 
together with the good news that the tumor was disappearing, strengthened them in 
coping this way. A positive attitude was perceived as a necessary condition to keep 
going and to have a life at all. The patients, and especially those with young children, 
also felt the need to be positive in order not to be a burden on their family.
An act of willpower
If you have negative thoughts yourself, you will only have negative people around you. You 
just have to think that there´s a life in spite of the lung cancer, it mustn´t rule my life. 
[female, age 47, ﬁrst interview]
Sometimes I can see that I´m not here any longer. My husband here alone. What will 
happen then? And then I think, no, stop! I´m still here, and we´ve not got that far yet. I´m 
here now. 
[female, age 56, ﬁrst interview]
I turn the tables and say, ´don´t be so stupid, we´re not going to go on like this, we´re going to 
ﬁght´, that´s my only chance of survival. 
[female, age 51, second interview]
As long as I feel all right I´m able to forget it. I have to, because otherwise I can´t go on. 
[male, age 69, second interview]
There´s a big chance that it will come back again. If you keep thinking about that, then you 
don´t have a life anymore. 
[female, age 42, third interview)
Box 2
After the course, i.e. “the period of relative peace of mind”, the patients started a new 
routine of regular check-ups at the clinic. These visits were welcomed, but feared at 
the same time. In some patients, fear of a recurrence was so strong that they actually 
wished to continue with chemotherapy. Others were very doubtful as to whether they 
would wish to receive more chemotherapy in case of a recurrence. However, when a 
relapse did occur, all accepted a new course, hoping to gain more time. Amy (age 42) 
even insisted on having a third course, although she knew that it was pointless: “I’ll
ﬁght till the bitter end, that’s my way”.
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Commitment to the family 
Family was perceived to be the most important factor contributing to QOL, but at the 
same time, especially in the initial period, it was also a focus of concern (see Box 3). 
All patients worried about their loved ones, and made a special effort to fulﬁl their 
established role in the family. Men ﬁrst checked and discussed ﬁnances and living 
conditions, and tried to do whatever was in their power to support and secure future 
family life. For example, a recently retired man exchanged his cherished car for a 
smaller one, which was more convenient for his wife; a young father arranged for a 
house in a safer area of the town for his family. Women were especially concerned 
with the continuation of family life and the household in general. Although they had 
to delegate tasks in the early stage of their illness, as soon as they could they tried to 
carry out their former tasks again and to restore the normal family life. 
However, during the course of the treatment family concerns abated. Patients who had 
perceived themselves primarily as the provider of support learned to accept and enjoy 
the support that was given to them. In some cases, this shift from concern to enjoyment 
seemed to be confusing for their spouses, who actually felt quite alone in their worries, 
and were anxious to discuss the observed physical deterioration. They did not want to 
destroy the hope by reacting negatively to remarks such as “I’m all right and I’m happy”.
Family
You have to cheer your family up yourself. If I were to cry all day, that would not be good 
for them. Besides, I still want to experience so many things. That keeps me strong. I really 
wouldn’t like think about the fact that someone else would have to bring up my children, 
and furthermore, we would also have a ﬁnancial problem. There are times when my wife and 
I discuss things like this.
[male, age 46]
I’ve suffered a lot, especially in the week after the ﬁrst treatment. I was so tired … my husband 
had to do everything … cooking. I hope that it will never happen again. I don’t like it at all. 
I want to do it myself. Ofcourse he did it with love, but even then …. The second treatment 
was less of a problem. I was able to do just what I wanted to do. As long as I can, I want to 
do it all by myself.
[female, age 63]
We’ve already arranged a lot. We’ve also taken a family photo with the children. But my 
husband is still very quiet, he doesn’t talk about it, I can’t reach him, and that’s hard for me. 
But, I think that’s his way of coping, so I let it go, I ﬁnd that’s the best way. I’m feeling tense 
towards him and the children, that’s why I want us all to enjoy ourselves together. Just a 
shortbreak, together in a holiday home, that would be nice and relaxing.
[female, age 53]
Box 3
The awareness of imminent death could cause a thorough shake-up of relationships. Lisa 
(age 64) for example, had taken care of her sick husband for seven years, and had expected 
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more support now that she herself was ill. She complained: “chemotherapy to prolong my 
burdensome life is quite useless”. When Lisa’s last treatment cycle was cancelled, because 
the tumor was not responding, the whole family suddenly took notice: her children and 
grandchildren visited her on a more regular basis and, for the ﬁrst time, she felt supported 
by her children. She did not complain anymore and created her own precious moments. 
Despite her husband’s disabilities, she picked up her life again and together they spent 
many happy times touring in the countryside which they both enjoyed.
Here-and-now: an art of living
During the ﬁrst course of chemotherapy
You don’t think about next year, what you’re going … you’re enjoying the daffodils that are 
coming up. Although I don’t feel well, I still try to enjoy things. 
[female, age 42]
You can’t forget, the cancer is there everyday. But I don’t do things just because I don’t have 
time left, that’s not the way to cope with the limited time. You have to think…If I honestly 
want to do something … then just do it. 
[male, age 68]
After the ﬁrst course
I usually ﬁnished the work in the garden in one day. Now it’s different, I rest more, your 
body is warning you. I’ve no trouble at all in splitting the work up in more days. What I 
can’t do today I’ll do tomorrow. 
[male, age 68]
My life seemed to be over when I heard the diagnosis. But after a while, suddenly, I could 
cope with it, it doesn’t matter anymore. We can accept what comes, we’re enjoying being 
together as long as possible.
 [male, age 69]
After the second course
I never knew that I was capable of it, and that it was so easy to live life day-by-day. 
[male, age 57]
I don’t worry anymore, that’s all over now. I wake up, it’s 6 o’clock, the sun is rising and I 
think to myself…a new day is coming for me to enjoy … how it will be tonight? We’ll see 
that when the time comes. 
[male, age 66]
Box 4
Living in the here-and-now
Regardless of how persistently and emphatically the patients stated that they were 
“doing all right”, the fabric of their positive stories was interwoven with threads of 
imminent death. Their seemingly random remarks masked their existential concerns 
and pain of loss. For example, Mark (age 39) said that he was very happy: “My friend 
and I bought a boat last week, and we’ve already had a marvellous trip. Actually I can’t 
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afford a boat on my salary, but you can’t wait till you’re retired, can you?”. Although 
he was happy and enjoying the moment, he had given up his his life-plan and his 
remark also expressed this loss. Living in the here-and-now (see Box 4) and enjoying 
the precious moments was advocated and aimed for, but not easily mastered. Ella 
(age 47), for example, suffered a lot from nausea during the treatment and protested 
strongly when this advice was given to her: “how can it ever be possible to enjoy life when 
you know that you will die, you feel miserable because of the chemo and you know that you 
won’t be able to see your son growing up”. Retired patients seemed to master the art of 
living in the moment more easily: “we’ll all die in the end, whether it’s from cancer or 
from something else. I will die, but not now, and meanwhile I’m going to enjoy the extra 
time”. Younger patients, who realized that they had to give up their work, hobbies 
and goals, such as seeing their children get married and becoming a grandparent, 
tried to make the best of their situation by redeﬁning what really mattered to them 
and by changing situational goals. Amy, for example, kept in touch with colleagues 
and supported them, and changed her hobby of gardening into one of making dolls, 
which were sold to raise money for local charities. In the last months of her life, 
walking became difﬁcult and she had to use a wheelchair when leaving the house. 
Altough her health was severely deteriorating after her three courses of chemo, she 
still felt that she had a high quality of life: “I’m still me you know, ﬁghting the cancer, but 
also enjoying my life. Actually, I think my quality of life is hundred percent. I’ve nothing to 
worry about, I enjoy the visits of colleagues, the weekend trips with my husband, the contacts 
with my children, and I don’t feel any pressure…”
Discussion
An important ﬁnding of our study is that the positive image which small-cell lung cancer 
patients might present to their doctors and relatives is neither just the result of their 
own evaluation of health, nor just the result of succesful adaptation and “practicing the 
art of living”.15 Patients seem to be continiously busy maintaining control by focusing 
on treatment, by anchoring themselves to a positive attitude, and by continuing their 
commitment to the family. Our results suggest that positive self-reports seem to show 
that patients are able to survive emotionally. However, it could also be argued that 
the expression “I’m all right” in itself is a useful strategy which enables patients to 
protect themselves from their own and people’s negative thoughts. Especially in the 
initial phase of treatment, when patients force themselves to stay positive, this way 
of presenting themselves might be a useful coping strategy in maintaining a sense 
of control in a situation which cannot be changed.16 Our ﬁndings also suggest that 
patients actually know their prognosis, but do not want to think about it and therefore 
try to focus on positive aspects. Therefore, self-presentation might also partially explain 
the “false optimism about recovery” in these patients, as described by The et al.13
Westerman_v3.indd   95 18-07-2007   13:01:02
C
h
ap
ter 6
96
Thompson et al. found that patients who perceive that they have control over their 
health are more capable of adjusting to illness.17 Their results indicate that even 
patients who were physically or psychosocially worse off were better adjusted if they 
had higher perceptions of control. Our ﬁndings suggest that especially through this 
sense of control patients are able to let go, to revise goals and expectations, and 
thus to enjoy life, despite their deteriorating health.11;18;19 The realistic appraisal of 
changing circumstances generates a positive affect, and is in line with the revised 
model of the coping theory20 in which positive mood and allocating meaning to a 
stressful situation has been integrated.21 But, it has to be remembered that the art of 
living with a terminal illness sometimes requires a daily need for willpower from the 
patients, and presumably also from their loved ones.
Conclusion
The dual role which physicians have in caring for terminally ill patients is not an 
easy one. Not all patients are prepared to discuss reality and their imminent death. 
However, the aknowledgement of a positive self-report as a product of the struggle 
for emotional survival, might open up the doctor-patient communication about 
end-of life issues without negating the importance of fostering hope. Explicitly 
acknowledging the patients’ efforts to maintain a sense of control can be a useful tool 
in the communication with patients who do not easily talk about their concerns,21-23
and it may promote satisfactory adjustment and quality of life.
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Discussion
The objective of our study was to obtain more insight into response shift in QoL 
measurement. During the study it was found that other phenomena were also 
important in explaining counter-intuitive ﬁndings, so we decided to investigate 
these phenomena as well. In the ﬁrst part of this chapter we will discuss the main 
results. In the second part we will answer the research questions listed in the General 
Introduction and describe the implications for research on quality of life (QoL) and 
response shift.
Over the past decades, there has been a growing interest in the impact of disease and 
treatment on a patient’s life and functioning. Systematic evaluations of QoL may 
enable clinicians not only to choose more easily between different treatment options, 
but also to identify patients who are at risk. For example, QoL was found to be a 
signiﬁcant predictor of survival in lung cancer patients.1 However, when patients are 
confronted with a life-threatening or chronic disease, they are faced with the necessity 
to adapt themselves to their deteriorating health. Response shift is considered to be 
an important mediator in this adaptation process.2 However, response shift has been 
found to complicate the interpretation of QoL outcomes. Therefore, integrating 
response shift into health-related QoL research would enhance the sensitivity and 
relevance of the research.3 But the question that arose was: how? 
Response shift
When our study was designed (1999), Sprangers and Schwartz had just developed their 
theoretical model.2 We therefore aimed to obtain more insight into response shift in 
QoL measurement by investigating whether the methods suggested by Schwartz and 
Sprangers3 were useful for the measurement of the three different aspects of response 
shift. However, soon after the initial analyses we found that ‘measuring’ the different 
aspects by means of the then-test and the SEIQoL-DW was much more complicated 
than we had expected (Chapter 2 and 5). The problems with the then-test in measuring 
recalibration were partly due to our longitudinal study design, which made it difﬁcult 
for patients to remember the previous assessment. The problem of recall bias had 
been already discussed by Schwartz et al.4 We assumed that a design in which the 
previous assessment is easier to remember, for example before and after a surgical 
operation, will produce less recall bias. But even so, it is debateable whether the then-
test is applicable in combination with a questionnaire such as the EORTC QLQ-C30. 
By observing the response behaviour in more depth we found that even when there 
is no recall problem, most of the questions about functioning in particular, are multi-
interpretable and therefore cannot be compared with the then-test questions which 
evaluate a patient’s functioning during the previous assessment (Chapter 3). From a 
theoretical point of view, the then-test could be questioned as well. An assessment 
of fatigue or pain here and now, when a patient can still feel the fatigue or pain, or 
when the patient is feeling happy to have recovered from the last cycle of treatment, 
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is totally different from remembering a certain moment in the past and recalling the 
feelings of that moment.
In the ‘measurement’ of response shift with the SEIQoL-DW we were confronted with 
the fact that the instrument has its risks which threaten its reliability (Chapter 4).
Preventive measures to overcome the risk of unnoticed interviewer bias cannot 
guarantee that in repeated measurements all the response shifts that occur are measured 
(Chapter 5). The advantage of using this instrument is that in the semi-structured 
interview the interviewer is able to elicit important information about what matters 
to the patient. However, this information must be recorded accurately. Because we 
audio-taped the interview, we were able to investigate response shifts, and this was 
furthermore productive in explaining the counter-intuitive QoL outcomes. However, 
audio-taping and analysing the verbatim of each assessment in order to investigate 
response shifts is time-consuming. Before a decision is made to use the SEIQoL-DW to 
measure response shift, researchers must think about 1) how to prevent interviewer 
bias, 2) how to record what the patients say when choosing the cues, and 3) how and 
when to use the prompt list. However, we see the possibilities of using the instrument 
in order to ﬁnd out what really matters to patients and to identify patients who have 
trouble in adjusting to their deteriorating health in a palliative setting. 
Change in appraisal
Our in-depth study of the response behaviour of patients in the assessment of QoL 
revealed phenomena which could explain counter-intuitive ﬁndings in QoL (Chapter 
2 and 3). In addition to self-presentation, which phenomenon we will discuss later, 
we found that QoL evaluations cannot be interpreted without considering the 
evaluation process. Our ﬁndings are most in line with the Rapkin and Schwartz 
process model for the evaluation of QoL, which has recently been published.5;6 Four 
appraisal processes are distinguished: 1) Induction of a frame of reference (referring to 
kinds of experiences that a person deems relevant), 2) recall and sampling of salient 
experiences, 3) standards of comparison used to appraise experiences, and 4) the 
subjective algorithm used to prioritize and combine appraisals to arrive at a QoL 
rating. Schwartz and Rapkin recommend the use of this model to investigate the 
cognitive processes underlying the evaluation of QoL. The model can easily explain 
that a change in appraisal is possible at each assessment and that, in addition to 
response shift, this change may explain counter-intuitive ﬁndings. Using their model 
in designing a new study might provide us with more insight into the evaluation 
process. However, asking patients to analyse each step of their evaluation is actually 
giving them the opportunity to formulate a different answer from that which they 
would have given without analysis of their evaluation in the proposed four steps, 
and this does not resemble ‘normal’ response behaviour. Furthermore, it could be 
questioned whether the ‘why’ question can be answered. Why are patients behave 
the way they do when answering the questionnaire? Why do we ﬁnd discrepancies 
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between answers to the questionnaire and the information given in the informal 
interview (Chapter 2)? 
Think aloud method
In answering the “why’ question, we found he think aloud method useful. One 
advantage of this method is that it closely resembles the normal process of evaluation, 
because observation has priority over the cognitive interview. Actually, the way in 
which we used the think aloud method was similar to a participant observation 
study in the measurement of QoL. With participant observation, phenomena are 
observed in their natural setting, which not only increases the validity of the data7,
but also enables the researcher to uncover routines (i.e. response behaviour) of which 
participants themselves may be unaware.8 However, the think aloud method also 
has it limitations. The participants are conscious of the researcher’s presence and 
may therefore be tempted to adapt their response behaviour (social desirability). 
Furthermore, thinking aloud while ﬁlling in a questionnaire is not a ‘normal’ activity. 
However, by interviewing the patients with SCLC several times, as we did, it is likely 
that they got used to the interviewer (MW) and the think aloud method, and probably 
reverted to their normal behaviour (if it had changed at all). What we did ﬁnd was 
that some patients said that they were more motivated to ﬁll in the questionnaire 
because: 1) someone was listening, 2) they had the opportunity to explain nuances 
in their answers, and 3) they felt that they were able to explain more clearly how they 
felt. Furthermore, the results of other studies of SCLC patients9 conﬁrm the pattern we 
found in the QoL outcomes of both the EORTC and the SEIQoL-DW (Chapter 3 and 
5): improvement at four weeks after the start of the chemotherapy, a slight decrease at 
the end, and an increase in the level of QoL six weeks after the chemotherapy.Taking 
this all into account, it is not likely that we have observed adapted behaviour which 
would have resulted in different QoL outcomes than we would have found without 
using the think aloud method. 
Self-presentation
The think aloud method uncovered response behaviour, of which the patients 
themselves might have been unaware. They tried to distance themselves from the 
image of the stereotype cancer patient, and presented themselves as not suffering 
and as accepting fatigue as a consequence of treatment and not only when ﬁlling 
in the questionnaire (Chapter 2). Even in the informal part of the interview they 
presented themselves as positive and not suffering, but at the same time they also 
talked about their sometimes daily struggle to cope with the diagnosis and treatment 
(Chapter 6). Especially during the ﬁrst course of chemotherapy the patients tend to 
anchor themselves to a positive attitude, and herewith to distance themselves from 
the prognosis. These ﬁndings seem to be in line with the results of the study in 
which The et al. investigated the ‘false optimism’ about recovery in SCLC patients.10
However, taking into consideration the fact that the patients made preparations 
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for their imminent death, and said that they knew that their cancer was incurable, 
it could be questioned whether the term ‘false optimism’ is accurate. Our study 
(Chapter 2) suggests that ‘self-presentation’ might be an important mechanism 
which explains the optimism and the positive reports in QoL measurement. Self-
presentation has been found to be used by patients as coping strategy which helps 
them to keep control over their life (Chapter 6). The patients tried to live as normally 
as possible, and to adopt and maintain a positive attitude. This was sometimes a daily 
struggle, but one which they considered to be necessary. They did not give up goals 
which were no longer tenable from one day to the other; control and adjustment 
went hand-in-hand. Feeling physically well seemed to be helpful in maintaining a 
positive attitude, but this does not necessarily mean that the patients did not know 
about their prognosis. They knew, but did not want to know, and tried to enjoy life 
as much as possible by living it as normally as possible. When we argue that self-
presentation is a coping strategy (Chapter 2), it would actually ﬁt into the theoretical 
model of response shift as one of the mechanisms.2 In an attempt to specify this type 
of coping it seems to resemble a combination of ‘redeﬁning’ and ‘confronting’, or in 
other words ‘accept but ﬁnd something favourable’ and ‘take ﬁrm action based on 
present understanding’, respectively, as described by Weisman in his book “Coping 
with cancer”.11 In Weisman’s words: “The effect of redeﬁning is to put a bad situation 
into a better, more benign, and acceptable light one, which must not be mistaken for 
denial. This reinterpretation is an excellent way of rationalizing illness into smaller 
complaints”. Weisman presents an example of a women who also minimized her 
complaints by blaming them on something other than her illness (see our Chapter 2)12,
and he argues that this coping strategy works best when combined with confronting. 
Without it, patients are reduced to avoidance and passivity. In our study we also 
observed the ﬁrm action patients take to keep control over their life. Although self-
presentation, as coping mechanism, seems to ﬁt into the model of the response shift 
theory, the results of our study have also shown that self-presentation is not identical 
to recalibration response shift, and complicates the investigation of response shift in 
a yet unknown way.
Answers to the research questions 
Q 1. Is the then-test a useful approach to determine whether a recalibration response shift 
has occurred?
In the qualitative investigation of the the response behaviour in the measurement 
of fatigue with the EORTC QLQ-C30 question ‘were you tired’, we found indications 
of recalibration response shift (e.g. using a different standard for comparison over 
time). However, it was difﬁcult to demonstrate recalibration by means of the then-
test (Chapter 2). The patients had difﬁculty in remembering either the previous 
measurement point and/or their fatigue at that time. Identical problems were 
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encountered in the physical and role functioning questions (1-7). In addition 
to recall bias, change in the way which patients sampled their experiences when 
interpreting and responding to the questions made the interpretation of the then-test 
data complicated. The then-test, in combination with the EORTC questionnaire, is 
not a reliable method of demonstrating recalibration during a treatment trajectory. 
Q 2. Can response shift sufﬁciently explain counter-intuitive ﬁndings in the measurement
of QoL?
There were discrepancies between the answers of 15 out of the 23 patients to 
the EORTC question ‘were you tired’ and the level of fatigue they spontaneously 
reported during the interview (Chapter 2). Although response shift occurred (i.e. a 
different standard of comparison over time, and a change towards a more optimistic 
perspective), this type of response shift was not only found in the discrepancy group. 
Patients in the discrepancy group reported spontaneously how they dealt with the 
diagnosis and treatment (i.e. by adopting protective and assertive behaviour and by 
ﬁghting the stigma). They distanced themselves from the image of the stereotype 
cancer patient and presented themselves as not suffering and accepting fatigue as 
a consequence of the treatment. Our study suggests that ‘self-presentation’ might 
be an important additional (coping) mechanism that affects QoL measurement and 
can explain counter-intuitive ﬁndings. Furthermore, the patients did not report the 
deterioration in physical and role functioning that would objectively have been 
expected (Chapter 3). The various response strategies (e.g. taking the wording of 
questions literally, guessing, and excluding activities which could not be performed) 
and the change in the patients’ appraisal process explained how levels of physical and 
role functioning were sustained under worsening physical conditions. In addition to 
response shift, self-presentation and change in the patients’ appraisal process were 
found to be additional mechanisms explaining counter-intuitive ﬁndings in QoL 
measurement.
Q 3. Is SEIQoL-DW a reliable instrument in providing all the relevant information that is 
needed to determine whether a response shift (i.e. reconceptualization and change in 
values) has occurred?
The SEIQoL-DW is an individualized approach to the measurement of QoL in which 
patients choose and deﬁne their own so-called ‘cues’. Our study showed not only 
the usefulness of the SEIQoL-DW in eliciting what matters to patients, but also the 
problems that are encountered when using this instrument (Chapter 4). Because cues 
originate from patient-interviewer interaction, the interviewer may inadvertently 
introduce bias while attempting to elicit cues, ultimately affecting the patients’ 
SEIQoL-DW score. There is a risk that repeated measurements do not provide all the 
information that is potentially available and relevant for investigating response shifts 
(i.e. reconceptualization and change in values)(Chapter 5). 
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Q 4. What are the factors that result in positive self-reports despite deteriorating health.
Adaptation through the eyes of the SCLC patient is sometimes a daily struggle (Chapter 
6). Although these patients make preparations for their imminent death, they tend 
to anchor themselves to a positive attitude, and herewith to distance themselves 
from their prognosis. They try keep control over their life by living it as normally as 
possible, by letting go those expectations and goals which are no longer tenable, and 
by simply enjoying life. Feeling physically well seemed to be helpful in maintaining 
a positive attitude, which was perceived to be ‘a necessary condition to have a life at 
all’, and resulted in positive self-reports despite deteriorating health.
Implications for research on QoL and response shift
Despite our study, the answer to the question of how to integrate response shift in 
QoL research is still not clear. But, by lifting the lid of the black box just a little while 
by listening to the patient who is ﬁlling in the questionnaire we have learnt more 
about how SCLC patients cope with their illness and how this coping affects the QoL 
measurement. An important issue which, to our knowledge, has never been discussed 
is the fact that when we present a patient with a cancer-speciﬁc QoL questionnaire, 
what we are communicating is that the patients has cancer. The patient probably 
feels stigmatized, and tries to distance him/herself from the image of the stereotype 
cancer patient. We have also learnt that it is possible to focus on what really matters 
in the palliative treatment of SCLC patients, and that the SEIQoL-DW is a useful 
instrument in communicating this type of information. But, above all, we know now 
that despite high levels of QoL, these patients have a lot of work to do, and we have 
to acknowledge their struggle behind words such as “I’m feeling ﬁne”. More research 
is certainly necessary and useful. However, we have to be aware that QoL outcomes 
may mainly reﬂect how patients are coping, in stead of measuring only the actual 
impact of cancer treatment. 
Final recommendations
1. Future research is needed to investigate the pros and cons of using of the prompt 
list in the SEIQoL-DW assessment 
2. We recommend further research on the possibilities of regular SEIQoL assessments 
in clinical practice to investigate: 1) whether and how patients are able to adjust 
to changing health, and 2) whether the obtained results can assist clinicians in 
identifying patients who need help in adjusting to their changing health.
3. Because each illness trajectory has its own characteristics, we recommend 
qualitative research to investigate background knowledge about the illness 
trajectory and appraisal processes. This is not only relevant for the design of 
quantitative studies, but also for the interpretation of QoL outcomes.
4. It is important to investigate in more depth the phenomenon of self-presentation in 
relation to QoL measurement and its place in the model of response shift theory. 
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Quality of life (QoL) is considered to be an important goal in clinical practice and 
particularly relevant to palliative medicine. However, there is an awareness that the 
patients’ own evaluations may differ considerably from those made by clinicians and 
signiﬁcant others. Actually, QoL research often yields counter-intuitive ﬁndings. The 
expected deterioration in QoL often does not occur, even in the case of serious illness. 
It is suggested that the occurrence of response shift (i.e. a change in the meaning 
of one’s self-evaluation as a result of a) a change in internal standards, b) a change in 
values or c) a reconceptualization) complicates the measurement of QoL, and may 
explain these discrepancies. Alternatively, response shift might be seen as a desirable 
outcome of adaptation. The aim of this thesis was to investigate: 1) the measurement 
of response shifts, 2) other phenomena to account for counter-intuitive ﬁndings in QoL 
measurement, and 3) adaptation from the perspective of the patient. 
In this study the following research questions were addressed (Chapter 1): 
1. Is the then-test a useful approach to determine whether a recalibration response 
shift has occurred?
2. Can response shift sufﬁciently explain counter-intuitive ﬁndings in the measurement 
of QoL?
3. Is SEIQoL-DW a reliable instrument in providing all the relevant information 
that is needed to determine whether a response shift (i.e. reconceptualization and 
change in values) has occurred?
4. What are the factors that result in positive self-reports despite deteriorating health.
We followed 31 patients with small-cell lung cancer during their illness trajectory. 
Patients who were evaluated for 1st line chemotherapy were informed about the study, 
invited to participate, and asked to give written consent. The patients were interviewed 
personally at home, they ﬁlled in written questionnaires (EORTC QLQ-C30 and QLQ-
LC13) according to a ‘think aloud’ and a ‘then-test’protocol, and individual QoL was 
assessed by means of the SEIQoL-DW. Our qualitative study included 4 measurements 
points during the ﬁrst course of chemotherapy (i.e. T1 at the start of the chemotherapy; 
T2 4 weeks after T1; T3 at the end of the chemotherapy; and T4 6 weeks after the end of 
the chemotherapy), and 2 measurements during a second or third course (i.e. at the start 
and at the end of these courses, respectively).
Listen to the patient
Chapter 2 reports on the response behaviour in the measurement of fatigue with 
the EORTC QLQ-C30 question ‘were you tired’. For 15 out of 23 patients there were 
discrepancies between their answer to the EORTC question ‘were you tired’ and the 
level of fatigue they spontaneously reported during the interview. These patients 
chose the response options ‘not at all’ or ‘a little’, and explained their answers in 
various ways. Patients in the discrepancy group reported spontaneously how they 
dealt with the diagnosis and treatment. They distanced themselves from the image 
of the stereotype cancer patient presenting themselves as not suffering and accepting 
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fatigue as a consequence of the treatment. The results of our study show that the 
question ‘were you tired’ in the EORTC-QLQ-C30 does not unequivocally measure 
the impact of chemotherapy on the energy level of a patient. Patients seem to give the 
impression that they are managing the situation, and this self-presentation may explain 
unexpected results. In patients with and without discrepancies, we found indications 
of recalibration response shift (i.e. using a different standard of comparison over 
time) and change in perspective (i.e. change towards a more optimistic perspective). 
However, it was difﬁcult to demonstrate recalibration by means of the then-test. The 
patients had difﬁculty in remembering either the previous measurement point and/
or their fatigue at that time.
Chapter 3 describes the response behaviour in the measurement of physical and role 
functioning. The terminally ill patients evaluated their functioning in terms of what 
they perceived to be normal under the circumstances. Various response strategies 
when answering questions about problems and limitations in functioning explained 
why the patients had scores suggesting that QoL was affected very little by the 
chemotherapy. For example, the patients focused on one aspect of the question, took 
the wording of the question literally, ignored or excluded certain activities which 
they could not perform, and guessed their level of functioning in activities which 
they did not perform. These strategies gave the impression that the patients were less 
limited than they actually were. Their answers could be interpreted best in terms of 
response behaviour, which has been described by Rapkin & Schwartz, and the change 
in their appraisal of QOL explained how levels of physical and role functioning were 
sustained under deteriorating physical health. 
Focus on what matters
Chapters 4 and 5 address the usefulness of the SEIQoL-DW (i.e. an individualized 
approach in the measurement of QoL in which patients can choose, value and weight 
ﬁve areas that they consider important for their quality of life) in the measurement of 
response shift. Chapter 4 reports on how patients choose and deﬁne the ﬁve areas, the 
so-called ‘cues’ and describes the problems that were encountered in the elicitation 
of cues. The instrument was found to be useful in eliciting what mattered to the 
patients. Many patients were eager to talk about sensitive issues. Family was the most 
frequently mentioned cue (i.e. patients named their partner, children, grandchildren 
and other family members) and some patients nominated more than one cue in 
this area. However, our study also demonstrated that eliciting cues implies that the 
interviewer makes decisions (e.g. about what to accept as a cue, whether and when 
to use the prompt list, and how to label and record the meaning of cues). SEIQoL-
DW data are therefore vulnerable for unnoticed bias, because of intra- and inter-
inconsistencies in the behaviour of the interviewer(s).
Chapter 5 describes the measurement of response shift with the SEIQoL-DW. 
Repeated measurements with the SEIQoL-DW generated data which showed that 
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the instrument had the potential to elicit important changes in priorities (i.e. the
nomination of other cues), changes in perspective (i.e. change within a cue), and
changes in values. Shifts in the perception of health, in particular, explained the high
levels of functioning in this area and their contribution to good overall QoL. The
audio-tapes of the interviews made it possible to assess these response shifts. There
is a risk that repeated measurements do not provide all the information which is
potentially available and relevant for the investigation of response shifts.
Understand the struggle
Chapter 6 describes adaptation through the eyes of the patient. The positive image
which the patients presented was neither just the result of their own evaluation of 
health, nor just the result of successful adaptation and ‘practicing the art of living’.
The patients actually knew their prognosis, but did not want to think about it,
and tried therefore to anchor themselves to a positive attitude in order to survive
emotionally. Especially through this sense of control the patients were able to let go,
to revise goals and expectations, and thus to enjoy life, despite their deteriorating
health. But, the art of living with a terminal illness sometimes required a daily need
for willpower from the patients, and presumably also from their loved ones.
Discussion
Chapter 7 contains a general discussion of the ﬁndings presented in this thesis, and
addresses implications for QoL and response shift research. Firstly, by listening to the
patient who is ﬁlling in the questionnaire we discovered that not only response shifts,
but also that self-presentation affects the QoL measurement. It will be a challenge
for QoL and response shift researchers to investige more in depth QoL appraisal, the 
phenomenon of self-presentation, and its place in the model of the response shift theory.
Secondly, patients are eager to talk about sensitive issues in the SEIQoL-DW assessment,
and the instrument is useful for investigating response shifts. We recommend that 
clear instructions are given to the interviewers, and accurate recording of the cues is
essential to overcome the risk of interviewer bias. New research should be encouraged
to investigate more in depth: 1) the use of the prompt list, and 2) the possibilities
of using the instrument in clinical practice to identify patients who need help in
adjusting to deteriorating health. Finally, our ﬁndings indicate that the positive self-
reports in the measurement of QoL may cover up the efforts that patients have to
make in order to survive physically, emotionally and socially, to keep going and still
enjoy life. QoL and response shift research will beneﬁt from investigating the struggle
behind “I’m allright”, by observing QoL measurement in the real life context during
the illness trajectory. Because each illness trajectory has its own characteristics, we
recommend qualitative research in order to enhance the interpretation of QOL
outcomes.
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In de klinische praktijk en met name in de palliatieve geneeskunde wordt kwaliteit 
van leven als een belangrijke uitkomstmaat beschouwd. Toch is men er zich ook van 
bewust dat er aanzienlijke verschillen kunnen zijn tussen het oordeel met betrekking 
tot de kwaliteit van leven zoals een patient die zelf maakt, en het oordeel zoals artsen 
en partners die maken. In feite zien we in kwaliteit van leven onderzoek dikwijls 
uitkomsten die tegen de intuitie indruisen. De verwachte verslechtering in kwaliteit 
van leven wordt soms niet gezien, zelfs niet in het geval van een ernstige ziekte. 
Er wordt verondersteld dat het fenomeen response shift hierbij een rol speelt. Response
shift wordt gedeﬁnieerd als een verandering in de zelfrapportage als gevolg van: a) 
een verandering in interne standaarden (recalibratie), b) een verandering in waarden 
(herprioritering), of c) een verandering in de betekenis van kwaliteit van leven zelf 
(reconceptualisatie). Response shifts kunnen worden gezien als een gewenst resultaat van 
het vermogen van de mens om zich aan te passen aan veranderende omstandigheden 
om zo het leven draaglijk te maken. Echter, response shift bemoeilijkt het meten van 
kwaliteit van leven en het interpreteren van veranderingen hierin. Dit proefschrift 
beschrijft de resultaten van het onderzoek ‘Response shift in kwaliteit van leven in de 
palliatieve behandeling van patienten met kleincellig long kanker’ dat als doel had 
te exploreren: 1) het meten van response shifts, 2) andere fenomenen die de tegen-
intuïtieve resultaten in kwaliteit van leven onderzoek zouden kunnen verklaren, en 3) 
aanpassing aan een veranderende gezondheidstoestand gezien vanuit het perspectief 
van de patient. 
De volgende vragen zijn in dit onderzoek beantwoord (hoofdstuk 1): 
1. Is de toen-test een bruikbare methode om vast te stellen of er een recalibratie 
response shift heeft plaatgevonden?
2. Kunnen de uitkomsten in kwaliteit van leven metingen die tegen de intuitie 
indruisen voldoende toereikend verklaard worden door response shift?
3. Is de SEIQoL-DW een voldoende betrouwbaar instrument in het verschaffen 
van de relevante informatie die nodig is om te bepalen of er response shift (i.e. 
reconceptualisatie en herprioritering) heeft plaats gevonden?
4. Welke factoren dragen bij aan de beleving van het hebben van een goede kwaliteit 
van leven ondanks een afnemende gezondheid?
We hebben 31 patienten met kleincellig long kanker tijdens hun ziekte traject gevolgd. 
Patienten die met een eerste lijn chemokuur zouden beginnen werden geïnformeerd 
over de studie en vervolgens uitgenodigd om deel te nemen en hun schriftelijke 
toestemming te geven. In onze kwalitatieve studie werden bij iedere patient 4 interviews 
rond de eerste chemokuur afgenomen (i.e. bij aanvang van de kuur, 4 weken later, 
na de laatste behandeling en 6 weeks na aﬂoop van de kuur) en 2 interviews bij een 
eventuele volgende chemokuurkuur (i.e. bij aanvang en na aﬂoop). De interviews 
werden bijna altijd bij de patient thuis gehouden. Ondere andere werden kwaliteit 
van leven vragenlijsten (EORTC QLQ-C30 and QLQ-LC13) ingevuld. Patienten werd 
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gevraagd hierbij hardop te denken aan alles wat er tijdens de beantwoording van de 
vragen door hen heen ging. Daarnaast werd de individule kwaliteit van leven gemeten 
met behulp van de SEIQoL-DW. Vanaf het tweede interview werd bovendien een 
zogenaamde ‘toen-test’ afgenomen met gebruik van de EORTC vragenlijsten. Hierbij 
werd gevraagd om terug te denken naar het moment van het vorige interview en de 
vragen te beantwoorden voor dat ‘toen’ moment. 
Luister naar de patiënt
Hoofstuk 2 gaat over hoe patiënten de vraag ‘was u moe’ van de EORTC QLQ-
C30 vragenlijst beantwoorden. Bij 15 van de 23 patiënten vonden we stelselmatig 
tegenstrijdigheden tussen hun antwoord zoals gegeven bij het invullen van de 
vragenlijst en dat wat deze patiënten spontaan vertelden over hun vermoeidheid 
op een ander meer informeel moment in het zelfde interview. Deze patiënten kozen 
de antwoordcategorie ‘helemaal niet’ of ‘een beetje’ en legden op allerlei manieren 
uit waarom dit zo was. In deze groep van patiënten zagen we ook dat spontaan 
verteld werd hoe men om ging met de diagnose en de behandeling. Deze patiënten 
leken zich af te zetten tegen het beeld van de stereotype kankerpatiënt en zichzelf 
te presenteren als niet lijdend en de vermoeidheid accepterend als behorend bij de 
behandeling. De resultaten van onze studie laten zien dat de vraag ‘was u moe’ van de 
EORTC-QLQ-C30 vragenlijst niet een helder en duidelijk antwoord kan geven op de 
vraag wat de invloed van de chemokuur is met betrekking tot vemoeidheid. Patiënten 
lijken het beeld te willen afgeven dat ze in staat zijn om om te gaan met de situatie, 
en deze ‘zelf-presentatie’ zou mede kunnen verklaren waarom de resultaten van 
kwaliteit van leven onderzoek soms anders zijn als verwacht. We vonden indicaties 
van recalibratie response shift (i.e het gebruik van verschillende standaarden in de 
tijd) en een verandering van een pessimistisch in een meer optimistisch perspectief. 
Maar het was moeilijk om recalibratie daadwerkelijk aan te tonen met gebruik van de 
toen-test. Dit omdat de patiënten het niet alleen moeilijk vonden om zich het vorige 
interviewmoment te herinneren maar ook niet meer precies wisten hoe moe ze zich 
toen hadden gevoeld. 
Hoofstuk 3 beschrijft het antwoordgedrag bij het meten van het fysieke en het rol 
functioneren. De ongeneeslijk zieke patiënten beoordeelden hun functioneren van 
uit hun idee van wat normaal was gezien de omstandigheden. De verschillende 
manieren waarop de patiënten de vragen beantwoordden over de ervaren problemen 
en beperkingen verklaarden waarom scoren kunnen suggereren dat de kwaliteit van 
leven weinig door de chemokuren is aangetast. De patiënten namen bijvoorbeeld de 
betekenis van woorden uit de vraag van de vragenlijst soms heel letterlijk, negeerden 
activiteiten die genoemd werden, namen activiteiten die ze niet meer konden doen 
niet meer mee in hun beoordeling, of probeerden te raden hoe beperkt ze waren in 
hun functioneren. Door op deze manieren de vragen te beantwoorden wekten de 
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patiënten via hun scoren de indruk dat zij minder beperkt waren dan zij feitelijk 
waren. Hun antwoordgedrag past binnen het verklaringsmodel zoals beschreven door 
Rapkin & Schwartz. Door de verandering in hun ‘appraisal’ zijn de kwaliteit van leven 
uitkomsten beter te begrijpen en is het te verklaren hoe het komt dat volgens de 
scoren het fysieke en rol functioneren nauwelijks achteruitgaat of gelijk blijft ondanks 
de afnemende fysieke gezondheidstoestand.
Focus op wat er echt toe doet
In de Hoofdstukken 4 en 5 wordt het meten van response shift met de SEIQoL-DW 
beschreven. Dit instrument beoogt de individuele kwaliteit van leven te meten doordat 
de patiënt niet alleen zelf gebieden kan noemen die hij/zij van belang vindt bij de 
beoordeling van kwaliteit van leven, maar ook kan aangeven welke gebieden het meest 
van belang zijn. Hoofdstuk 4 laat zien hoe de vijf te kiezen gebieden, de zogenaamde 
‘cues’ gekozen worden, en beschrijft de problemen tijdens het kiezen van deze cues. 
Door dit instrument te gebruiken bleek het mogelijk om in beperkte tijd belangrijke 
informatie te verkrijgen over wat er echt toe doet voor de individuele patiënt. Familie 
werd het meest genoemd , ze noemden hun man, vrouw, kinderen, kleinkinderen of 
andere familieleden. Sommigen noemden meer dan één cue die te maken had met 
familie. Onze studie heeft echter ook laten zien dat het kiezen van de cues impliceert 
dat de interviewer keuzes maakt tijdens dit proces (bijvoorbeeld wat te accepteren als 
cue, of en wanneer er hulp wordt geboden door middel van het aanbieden van een lijst 
met topics, de zogenaamde ‘prompt’ lijst, en hoe dat wat is gezegd van een label wordt 
voorzien en de betekenis daarvan wordt opgeschreven). De SEIQoL-DW blijkt gevoelig 
te zijn voor bias, omdat zowel inconsistenties in het gedrag van de interviewer zelf als 
ook tussen interviewers onopgemerkt kan blijven.
Het meten van response shift met de SEIQoL-DW komt aan bod in Hoofdstuk 5. 
Het herhaald afnemen van de SEIQoL-DW leverde data op die lieten zien dat het 
instrument het potentieel heeft om de response shifts vast te kunnen leggen. Door het 
noemen van andere cues en ook door een verandering in de betekenis en de weging 
van een cue werd zichtbaar hoe de patient zich had aangepast aan zijn veranderde 
omstandigheden. Met name een verandering in de betekenis van gezondheid kon de 
hoge kwaliteit van leven score verklaren. Deze response shifts konden we vooral goed 
onderzoeken omdat het gesprek tussen de interviewer en patiënt tijdens de afname 
van het instrument was opgenomen op de band. Als het gesprek en de cues met hun 
betekenis niet goed worden opgeschreven of op band wordt opgenomen bestaat er het 
risico dat informatie die relevant is om te bepalen of er response shifts zijn opgetreden 
wordt gemist.
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Begrijp de strijd
Hoofdstuk 6 laat ‘aanpassing’ zien vanuit het perspectief van de patiënt. “I’m allright” 
of wel “het gaat goed met mij” is iets dat patiënten niet alleen kunnen zeggen omdat 
het goed met ze gaat, of omdat ze zich goed hebben aangepast, en zich de kunst eigen 
hebben gemaakt om te leven in het hier en nu. In feite waren ze op de hoogte van 
hun prognose, maar ze wilden er niet aan denken, en ze probeerden zich volledig te 
richten op het hebben van een positieve houding om emotineel te kunnen overleven. 
Door deze gerichtheid op het positieve en het uitspreken van “het gaat goed met mij” 
hield de patiënt een gevoel van controle en juist daardoor was hij/zij in staat om los 
te laten, doelen en verwachtingen bij te stellen en te genieten van het leven ondanks 
een afnemende gezondheid. Maar deze kunst om te leven met een ongeneeslijke ziekte 
vereiste ook wilskracht en ging soms gepaard met een dagelijkse strijd, niet alleen voor 
deze patiënten maar waarschijnlijk ook voor de mensen dicht om hen heen. 
Discussie
Hoofstuk 7 bevat de algemene discussie met betrekking tot de resultaten zoals gepresen-
teerd in dit proefschrift en bespreekt de implicaties hiervan voor kwaliteit van leven en 
response shift onderzoek. Door allereerst te luisteren naar de patiënt die de vragenlijst 
invult ontdekten we dat niet alleen response shifts, maar ook zelf-presentatie van 
invloed is op de kwaliteit van leven meting. Allereerst zal het een uitdaging zijn voor 
kwaliteit van leven en response shift onderzoekers om niet alleen ‘appraisal’ verder 
te onderzoeken maar ook het fenomeen zelf-presentatie en haar plaats binnen de 
response shift theorie. Daarnaast is ook het meten van response shifts met de SEIQoL-
DW interessant om verder te onderzoeken, juist omdat er zoveel informatie door de 
patient wordt gegeven over wat er (voor hem of haar) echt toe doet. We raden daarbij 
wel aan om de interviewers heldere instructies mee te geven om bias te voorkomen 
en ook de cues en hun betekenis goed vast te leggen. Verder onderzoek is nodig naar 
het gebruik van de ‘prompt’ lijst bij het kiezen van de cues en de mogelijkheden van 
gebruik van dit instrument in de klinische praktijk bij het signaleren van problemen 
in de aanpassing aan een afnemende gezondheid. Tot slot laten onze bevindingen 
zien dat positieve uitkomsten in kwaliteit van leven onderzoek vaak het werk 
versluieren dat deze patiënten moeten doen om überhaupt fysiek, emotioneel en 
sociaal op de been te blijven, om door te gaan met hun leven en daar ook nog van 
te genieten. Kwaliteit van leven en response shift onderzoek zal baat bij hebben het 
onderzoeken van de strijd achter “I’m allright”, door de patiënt te observeren bij de 
kwaliteit van leven metingen gedurende het ziektetraject. Omdat ieder ziektetraject 
zijn eigen speciﬁeke karakteristieken heeft kan kwalitatief onderzoek waardevol zijn 
om de kwaliteit van leven uitkomsten beter te kunnen interpreteren. 
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Nabeschouwing
In dit proefschrift heb ik verslag gedaan van ons onderzoek naar de zogenaamde 
‘response shift in kwaliteit van leven’ bij mensen die wisten dat hun longkanker niet 
meer te genezen was. Uit de gesprekken kwam naar voren dat ‘aanpassen’ aan het 
feit dat je een ongeneeslijke ziekte hebt… aan het feit dat je fysiek achteruitgaat… 
aan het feit dat je levensplan anders verloopt als verwacht… niet gaat zonder 
slag of stoot, ook al blijkt dit niet altijd af te lezen uit de kwaliteit van leven zoals 
gescoord op vragenlijsten. Omdat de vragenlijsten niet werden toegezonden per 
post, maar door mijzelf werden afgenomen bij de mensen thuis heb ik beter kunnen 
begrijpen wat het betekent om een ongeneeslijke ziekte te hebben en daarvoor 
chemokuren te ondergaan. Daarom ook “The struggle behind I’m allright” als titel 
van mijn proefschrift. Niet alleen uit respect en bewondering, maar bovenal ook uit 
dankbaarheid voor de openheid waarmee mensen met mij spraken en mij leerden 
over hun worsteling om er toch te zijn, er te zijn voor hun familie, er te zijn om te 
leven…in het hier en nu en dat in de wetenschap dat hun tijd beperkt was…zoals 
iemand zei: “Het gaat goed met mij, maar het leven is transparant geworden, de dood is 
steeds op de achtergrond aanwezig”.
Ik heb het hele land afgereisd, heel wat kilometers gemaakt met mijn oude Volvo, 
de kofﬁe stond altijd klaar en in Brabant soms met het burenbezoek erbij. Afspraken 
maken was niet altijd makkelijk. Is er ooit een goed moment om af te spreken voor 
een interview vlak na de diagnose kanker…als je hele leven overhoop ligt? Wat zeg 
je als je graag weer wilt afspreken voor een interview als het moment daarvoor nog 
onbekend is… als de kanker weer terug is gekomen… bij de start van een 2e kuur? 
Kan je… mag je dat eigenlijk wel vragen? Ook afscheid nemen hoorde er bij. Soms 
heel onverwacht, zoals bij een patiënt die ik bezocht 6 weken na de kuur voor het 
4e interview. Hij lag op het moment van mijn aanbellen op sterven. Zijn vrouw had 
er niet meer aan gedacht dat ik zou komen. Op zo’n moment was ik blij dat ik niet 
meer zo jong was… dat ik geleerd had in mijn leven om niet te schrikken van mijn 
emoties en van die van de ander… dat ik kon zijn... in het hier… in het nu. Vaak 
stopte ik mijn auto na een interview op een rustig plekje… weg van de snelweg. 
Even alles laten bezinken, wat aantekeningen maken en alles los laten. Loslaten om 
weer thuis te kunnen komen en er ook daar weer te zijn. Niet alleen het leven van de 
patiënten en hun familie, ook mijn leven is in die tijd meer transparant geworden… 
geboorte, ziekte, dood … blijdschap en verdriet…. het was er allemaal… soms heel 
indringend… in één en hetzelfde moment…het moment van het leven zelf.  Kwaliteit 
van leven hebben? Toen ik startte met het onderzoek heb ik eens gezegd dat kwaliteit 
van leven niet is af te meten aan alles wat in dat leven aanwezig is… aan wat je hebt, 
aan wat je fysiek kan etc.! De patiënten met wie ik heb mogen spreken hebben me 
laten ervaren dat kwaliteit van leven alles te maken heeft met hoe je er bent… met een 
kwaliteit van zijn die zich moeilijk laat meten.
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Dankbetuiging
Promoveren doe je niet alleen en daarom een woord van dank aan allen die direct 
of indirect een belangrijke rol hebben gespeeld bij de totstandkoming van dit 
proefschrift. Allereerst nogmaals de patiënten die de tijd hebben genomen om met 
mij vragenlijsten in te vullen en met mij zo openhartig wilden spreken. Dank ook 
aan hun familie die vaak klaar stond om mij te ontvangen, om zich vervolgens weer 
discreet terug te trekken voor het interview begon. Ook dank aan de longartsen van 
de diverse ziekenhuizen die deelnamen in het onderzoek. Zij hebben zich enorm 
ingezet bij de inclusie van de patiënten. Het zal vast niet makkelijk zijn geweest om 
mensen die slecht nieuws te verwerken kregen te vragen om aan onderzoek deel te 
nemen.
Terugblikkend op de jaren waarin dit proefschrift vorm kreeg wil ik alle collega’s van 
het EMGO en met name van de afdeling Sociale Geneeskunde van de VU bedanken 
voor de samenwerking, de vriendschappen en de gezellige momenten. Ook buiten de 
VU waren er mensen die mij stimuleerden en die er toe hebben bijgedragen dat dit 
proefschrift afkwam. Een aantal wil ik hier persoonlijk bedanken.
Allereerst Tony, mijn projectleider en co-promotor. Tony, je vroeg een schaap met 
vijf poten toen ik solliciteerde op deze ‘baan’. Of ik dat ook voor je ben geweest? Ik 
hoor het graag nog eens van je. Je ging weg bij de VU, vertrok naar Rotterdam, toen 
ik net begon met het onderzoek. Toch was je er altijd als het nodig was en ik heb 
ongelofelijk veel van je mogen leren deze jaren.
Dan Anne-Mei The, mijn tweede co-promotor en waanemend projectleider. Door 
mijn verhalen over de patiënten met jou te delen, en dit soms onder het genot van 
een heerlijke lunch, groeide mijn inzicht. Jij hielp me altijd weer op weg en niet 
alleen met je grote vertrouwen in mij dat het wel zou lukken. Dank je daarvoor en 
voor de smsjes om mij te vragen hoe het ging, of om even in het weekend te melden 
dat je blij was met wat ik had geschreven. Ik hoop ook in de toekomst nog veel van 
je te leren en met je samen te werken.
Gerrit van der Wal, jij was mijn promotor gedurende het gehele traject, zelfs nu je 
alweer bijna een jaar een andere baan hebt. Ik dank je voor het vertrouwen dat  je 
bleef houden in mij ondanks een fors uitlopend traject. Ook dank voor de snelle en 
adequate reacties en het opbouwend commentaar tot en met de komma’s en puntjes 
op de i.
Als 4e lid van de projectgroep wil ik ook Harry Groen bedanken. Harry, je stond aan de 
wieg van ons project, want je was er al bij betrokken nog voor je wist wie het onderzoek 
zou gaan uitvoeren. Uiteindelijk kwam de gehele groep maar zelden bij elkaar. Maar 
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je kwam dan toch helemaal over uit Groningen. Vooral wil ik je bedanken voor de 
wijze waarop je me hebt ‘ingewijd’ in alles wat er rond de SCLC patiënt gebeurt in het 
ziekenhuis en op de polikliniek.
Mirjam Sprangers, je hoorde niet ofﬁcieel tot onze projectgroep, maar was er wel op 
de achtergrond. Je adviezen, jouw kritisch commentaar, de wijze waarop je de tijd 
voor me nam die je eigenlijk niet had, een artikel met mij doorspreken per telefoon 
vlak voor je weer afreisde naar het hoge Noorden…ik ben er trots op dat jij met mij 
wilde meedenken. Bedankt!
Michael Echteld, jij leerde mij het gebruik van de SEIQoL-DW. Wat was ik blij dat je 
na een kort uitstapje (ook al naar Rotterdam) toch weer bij de VU kwam werken en 
mij wilde adviseren bij het schrijven van één van mijn artikelen.
Interviews moeten worden uitgetypt. Minou Adami, de meeste van de ruim honderd 
interviews zijn door jou uitgetypt. Ook Esther Marcus en Juun Vogel hebben heel wat 
banden afgeluisterd en uurtjes getypt. Bedankt jullie! 
Artikelen die ingediend gaan worden bij een tijdschrift moeten ook nagekeken worden 
op correct gebruik van de Engelse taal. Faith Maddever, je was daarvoor onmisbaar!
Graag bedank ik ook de leden van de promotiecommissie: Prof.dr. N.K. Aaronson, 
Prof.dr. D.L. Willems, Prof.dr. P.E. Postmus, Dr. F. van Zuuren en Dr. M. Echteld.
De collega’s van het secretariaat wil ik ook niet onvermeld laten. Rita, jij was in mijn 
begintijd als secretaresse van Gerrit altijd een eerste praatpaal en vraagbaak voor mij. 
Je betrokkenheid bij de AIO’s vond ik bijzonder. Ik weet niet of ik nu de laatste AIO 
ben uit ‘jouw tijd’, maar ik weet wel zeker dat je je best zult doen om ook bij mijn 
verdediging te zijn. Manigeh en Inge, ook jullie bedankt voor de kleine klusjes en de 
adviezen!
Dan ook nog speciaal 3 collega’s met wie het goed was om de kamer te delen en 
sloten kofﬁe weg te werken. Annemieke, jij was al gepromoveerd, daarom konden 
we veel van je leren. Harm-Jan en Sander, wat konden jullie kletsen af en toe… en 
tafeltennissen omdat de computer aangaf dat het weer tijd was. Dank voor jullie 
steun!
Buiten de VU zijn er ook mensen om te bedanken, mensen die er altijd waren voor 
mij en mijn gezin. Ted, samen hebben we gezorgd voor een stevige basis, in mijn 
ogen onmisbaar bij het doen van dit soort van onderzoek. Rob, je woont soms te 
ver weg naar mijn zin, maar bedankt dat je mij weer het juiste perspectief kan laten 
zien als dat nodig is. Ria, niet alleen een heel bijzondere vriendin, maar ook steun en 
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toeverlaat. Je weet zelf waarom jouw werk er toe heeft bijgedragen dat ik (weer even) 
zonder zorgen aan mijn proefschrift kon werken. Joep en Ineke, ﬁjn om mensen in 
de buurt te hebben bij wie je bij nacht en ontij terecht kan.
Dan nog mijn familie, mijn ouders en in het bijzonder mijn kinderen. Jullie hebben 
nauwelijks kunnen bevatten waar ik allemaal mee bezig was en al evenmin waarom 
het nog steeds maar niet klaar was. Dat je om te kunnen promoveren erg veel 
doorzettingsvermogen nodig hebt en heel hard moet werken alvorens de klus te 
kunnen klaren is jullie nu wel duidelijk. Jan en Bep, het is ﬁjn om te voelen dat 
je ouders zo met je meeleven! Jan, Harm en Lise, fantastisch om zulke zelfstandige 
kinderen te hebben die er mee konden leven dat ik al heel vroeg in de ochtend 
vertrok naar de VU en soms ook weer veel te laat in de avond thuis kwam. Dat al het 
aanwezige lekkers ondertussen soms op raadselachtige manier uit huis verdween…
dat waren vast de kaboutertjes… want over jullie had ik niets te klagen. Eindexamen 
doen, overgaan, alles ging thuis gewoon door en dat zonder al te veel hulp van mijn 
kant! Beatrijs en Gijs (en natuurlijk ook Peter en Diana), jullie zijn er altijd voor mij 
en voor Jan, Harm en Lise als dat nodig is. Ik ben heel blij en trots dat jullie mijn 
paranimfen zullen zijn.
Als laatste… als eerste ben jij al genoemd… Frans! Jij was er altijd… jij bent er nu… 
zonder jou was er geen proefschrift. Jij en ik kennen de strijd en het werk dat nodig 
is om in alle eerlijkheid en met respect voor elkaar afscheid te kunnen nemen. Het 
is het mooiste geschenk dat we elkaar nog hebben kunnen geven aan het einde van 
jouw leven….I’m allright!
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Marjan Westerman werd geboren op 15 juli 1951 in Hilversum. Zij behaalde in 1969 
haar Gymnasium B diploma aan het Christelijk Lyceum Hilversum en studeerde in 
1973 af als fysiotherapeut bij “Leffelaar” Amsterdam. In de jaren daarna volgde zij 
verschillende specialisatie cursussen waaronder de Bobath opleiding bij het Goois 
Kinder Ziekenhuis te Huizen en de opleiding tot haptotherapeut (A en B) aan de 
Academie voor Haptonomie te Doorn. Zij was eerst als kinderfysiotherapeut 6 jaar 
verbonden aan de Rooms Katholieke Ziekenverpleging Hilversum en startte vervolgens 
in 1979 haar eigen fysiotherapie praktijk in het bejaardenhuis St. Carolus. In 1986 
opende zij ook een praktijk voor haptotherapie. Naast het werk in haar praktijken 
was zij in Hilversum vele jaren werkzaam als docent pre- en postnatale educatie bij 
de Kruisvereniging en als gastdocent bij de verpleegkunde opleidingen van de drie 
ziekenhuizen. Zij was verder betrokken bij de ontwikkeling en de uitvoering van 
de cursus “Pre- en Postnatale Educatie” van de Stichting Wetenschap en Scholing 
Fysiotherapie in Amersfoort. Rond 1990 begon zij met haar universitaire studie en 
vanaf dat moment werkte zij alleen nog (tot 1998) als haptotherapeut. Zij behaalde 
haar doctoraal bul in 1999 aan de Faculteit der Wijsbegeerte van de Universiteit van 
Utrecht. Haar afstudeerrichting betrof de Praktische Filosoﬁe met het accent op Bio-
ethiek en Beleid & Organisatie van de gezondheidszorg. In september 2000 kwam zij 
in dienst bij het EMGO op de afdeling Sociale Geneeskunde van de Vrije Universiteit 
te Amsterdam en startte daar met haar onderzoek zoals beschreven in dit proefschrift. 
In de jaren 2005 en 2006 werkte zij op zeer kleine schaal weer als haptotherapeut. 
Sinds 2006 werkt zij bij de Faculteit der Aard- en Levenswetenschappen van de VU. 
Zij is als bachelorcoördinator, stagecoördinator en docent kwalitatieve methoden 
verbonden aan de afdeling Methodologie en Biostatistiek voor de opleiding Gezond-
heidswetenschappen. Marjan is zeker ook de trotse moeder van vijf kinderen, en oma 
van twee kleinkinderen.
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